% !TeX spellcheck = en_US
% !TeX encoding = UTF-8
\documentclass{beamer}

\mode<presentation> { \usetheme{Madrid} }

\usepackage{graphicx, graphics}
\usepackage[notocbib]{apacite}
\usepackage[style=iso]{datetime2}
\usepackage{enumerate}
\usepackage{multirow}
\usepackage{booktabs}
\DeclareGraphicsExtensions{.pdf, .png, .jpg, .gif}

\AtBeginSection[]
{
    \begin{frame}
        \vfill
        \centering
        \begin{beamercolorbox}[sep=8pt, center, shadow=true, rounded=true]{title}
            \usebeamerfont{title}
            \thesection. \insertsectionhead
            \par
        \end{beamercolorbox}
        \vfill
    \end{frame}
}

\AtBeginSubsection[]
{
    \begin{frame}
        \vfill
        \centering
        \begin{beamercolorbox}[sep=8pt, center, shadow=true, rounded=true]{title}
            \usebeamerfont{title}
            \thesection. \insertsectionhead
            \par
        \end{beamercolorbox}
        \begin{beamercolorbox}[sep=4pt, center, shadow=true, rounded=true]{title}
            \usebeamerfont{subtitle}
            \thesection.\thesubsection. \insertsubsectionhead
            \par
        \end{beamercolorbox}
        \vfill
    \end{frame}
}

\AtBeginSubsubsection[]
{
    \begin{frame}
        \vfill
        \centering
        \begin{beamercolorbox}[sep=8pt, center, shadow=true, rounded=true]{title}
            \usebeamerfont{title}
            \thesection. \insertsectionhead
            \par
        \end{beamercolorbox}
        \begin{beamercolorbox}[sep=4pt, center, shadow=true, rounded=true]{title}
            \usebeamerfont{subtitle}
            \thesection.\thesubsection. \insertsubsectionhead
            \par
        \end{beamercolorbox}
        \begin{beamercolorbox}[sep=3pt, center, shadow=true, rounded=true]{title}
            \usebeamerfont{subtitle}
            \thesection.\thesubsection.\thesubsubsection. \insertsubsubsectionhead
            \par
        \end{beamercolorbox}
        \vfill
    \end{frame}
}

\title[Lung Precancer Analysis]{Lung Precancer Analysis}

\author[Jaewoong Lee]
{
    Jaewoong Lee
    \and
    S. Park
    \and
    Y. Choi
    \and
    I. Yun
    \and
    Semin Lee
}

\institute[UNIST BME]
{
    Department of Biomedical Engineering
    \newline
    Ulsan National Institute of Science and Technology
    \medskip
    \newline
    \textit{jwlee230@unist.ac.kr}
}

\date{\today}

\begin{document}
    \begin{frame}
        \titlepage
    \end{frame}

    \begin{frame}
        \frametitle{Overview}
        \tableofcontents[hideallsubsections]
    \end{frame}

    \section{Introduction}
    \subsection{Lung Cancer}
    \begin{frame}
        \frametitle{Lung Cancer?}

        \begin{block}{The most common cancer}
            12.3 \% of all cancers \cite{lung3}
        \end{block}

        \begin{block}{The most important factor}
            \textbf{Tobacco}
        \end{block}
    \end{frame}

    \begin{frame}
        \frametitle{Cancer Survival Rate in Korea}

        \begin{figure}
            \includegraphics[width=\linewidth]{figures/LungCancer/rate.png}
            \caption{Common cancer survival rates \protect\cite{lung6}}
        \end{figure}

        \begin{block}{Survival rate (More than 5 year)}
            \begin{itemize}
                \item Tyroid: 68.4 \%
                \item Lung: 35.4 \%
            \end{itemize}
        \end{block}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Type of Lung Cancer}

        Types of lung cancer \cite{lung2}:
        \begin{enumerate}
            \item Adenocarcinoma (LUAD) (40 \%) $\bigstar$
            \item Squamous cell carcinoma (LUSC) (25 \%) $\bigstar$
            \item Small cell carcinoma (20 \%)
            \item Large cell carcinoma (10 \%)
            \item Adenosquamous carcinoma ($<$ 5 \%)
            \item Carcinoid ($<$ 5 \%)
            \item Bronchioalveolar (Bronchial gland carcinoma)
            \item ...
        \end{enumerate}

        \begin{figure}
            \includegraphics[width=0.5 \linewidth]{figures/LungCancer/classification.png}
            \caption{Lung cancer classification \protect\cite{NSCLC-3}}
        \end{figure}
    \end{frame}

    \subsection{Non-small cell lung cancer}
    \begin{frame}
        \frametitle{Non-small cell lung cancer (NSCLC)}

        Types of NSCLC \cite{NSCLC-1}:
        \begin{itemize}
            \item Adenocarcinoma (ICDO 8140/3)
            \item Squamous cell carcinoma (ICDO 8070/3)
            \item Large-cell carcinoma (ICDO 8012/3)
            \item ...
        \end{itemize}
    \end{frame}

    \subsection{LUAD}
    \begin{frame}
        \frametitle{LUAD}

        TCGA LUAD \cite{LUAD-1}
        \begin{itemize}
            \item 81 \% patients reported past/present tobacco smoking.
            \item Candidate driver genes: RTK, RAS, and RAF (38 \%)
            \item Cancer-associated mutations: KRAS (32 \%), EGFR (11 \%), and BRAF (7 \%)
            \item Enriched mutations: TP53, KEAP1, NF1, and RIT1 ($p < 0.01$)
            \item Fusions: ROS1 and RET
        \end{itemize}
    \end{frame}

    \subsection{LUSC}
    \begin{frame}
        \frametitle{LUSC}

        TCGA LUSC \cite{LUSC-1}
        \begin{itemize}
            \item 96 \% patients reported past/present tobacco smoking.
            \item Not present EGFR and ALK fusions.
             \item Recurrent mutations: TP53, NFE2L2, KEAP1, BAI3, FBXW7, GRM8, MUC16, RUNX1T1, STK11, and ERBB4
            \item High rate of copy number alteration compared with other TCGA projects.
            \item Amplication of NFE2L2, MYC, CDK6, MDM2, BCL2L1, and EYS.
            \item Deletion of FOXP1, PTEN, and NF1
        \end{itemize}
    \end{frame}

    \subsection{LUAD vs. LUSC}
    \begin{frame}[allowframebreaks]
        \frametitle{LUAD vs. LUSC}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.3 \linewidth]{figures/LungCancer/ADC.png}
                &
                \includegraphics[width=0.3 \linewidth]{figures/LungCancer/SQC.png}
                \\
                \mbox{(a) LUAD} & \mbox{(b) LUSC} \\
            \end{array}$
            \caption{LUAD and LUSC histology in Lung cancer \cite{lung4}}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/LungCancer/wang1.png}
                &
                \includegraphics[width=0.4 \linewidth]{figures/LungCancer/wang2.png}
                \\
                \mbox{(a) All patients} & \mbox{(b) By cancer stages} \\
            \end{array}$
            \caption{Kaplan-Meiere survival curves for LUAD \& LUSC \cite{lung5}}
        \end{figure}

        \begin{block}{Findings}
            LUSC is more dangerous than LUAD. $\because p < 0.001$
        \end{block}
    \end{frame}

    \subsection{Study Objectives}
    \begin{frame}
        \frametitle{Study Objectives}

        \begin{block}{Find different mutations}
            \begin{itemize}
                \item between WES vs. WTS
                \item from cancer vs. precancer
            \end{itemize}
        \end{block}

        \begin{block}{Ultra-deep sequencing}
            to find an \textit{infinitesimal} quantity of Non-Circulating Tumor DNA
            \begin{itemize}
                \item from blood
                \item from urine
                \item from bronchus
            \end{itemize}
        \end{block}
    \end{frame}

    \section{Materials}
    \begin{frame}
        \frametitle{Lung Cancer Data}

        \begin{itemize}
            \item Exome (WES) (sample $n$=289) \\
                + Transcriptome (WTS) (sample $n$=166)
            \item Normal + \{Dysplasia, AAH, CIS + AIS, MIA\} + Primary
            \begin{itemize}
                \item Adenocarcinoma in situ
                \item Atypical adenomatous hyperplasia
                \item Carcinoma \textit{in situ}
                \item Dysplasia
                \item Minimally invasive adenocarcinoma
            \end{itemize}
            \item Adenocarcinoma (LUAD) \& Squamous cell carcinoma (LUSC)
            \begin{enumerate}
                \item Normal $\rightarrow$ AAH $\rightarrow$ AIS $\rightarrow$ MIA $\rightarrow$ LUAD (patient $n$=18)
                \item Normal $\rightarrow$ Dysplasia $\rightarrow$ CIS $\rightarrow$ LUSC (patient $n$=77)
            \end{enumerate}
        \end{itemize}
    \end{frame}

    \subsection{WES Data}
    \begin{frame}
        \frametitle{WES Data Composition}

        \begin{table}
            \caption{Number of WES samples}
            \resizebox{!}{0.3 \textheight}
            {\input{tables/WES_samples/WES_samples.tex}}
        \end{table}
    \end{frame}

    \subsection{WTS Data}
    \begin{frame}
        \frametitle{WTS Data Composition}

        \begin{table}
            \caption{Number of WTS samples}
            \input{tables/WTS_samples/WTS_samples.tex}
        \end{table}
    \end{frame}

    \section{Methods}
    \subsection{Workflows}
    \begin{frame}
        \frametitle{Data pre-processing for variant discovery}

        \begin{figure}
            \includegraphics[width=0.3 \linewidth]{figures/Workflow/mapping.png}
            \caption{Data pre-processing for variant discovery \protect\cite{gatk1, gatk2}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Somatic short variant discovery}

        \begin{figure}
            \includegraphics[width=0.7 \linewidth]{figures/Workflow/somatic_short_variants.png}
            \caption{Somatic short variant (SNVs + Indels) discovery workflow \protect\cite{gatk1, gatk2}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Germline short variant discovery}

        \begin{figure}
            \includegraphics[width=0.7 \linewidth]{figures/Workflow/germline_short_variant.png}
            \caption{Germline short variant (SNVs + Indels) discovery workflow \protect\cite{gatk1, gatk2}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{RNA-seq short variant discovery}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/Workflow/RNA_short_variant.png}
            \caption{RNA-seq short variant (SNVs + Indels) discovery workflow \protect\cite{gatk1, gatk2}}
        \end{figure}
    \end{frame}

    \section{Results}
    \subsection{Quality Checks}
    \subsubsection{Quality Checks with Size}
    \begin{frame}
        \frametitle{File Size in WES Data}

        \begin{figure}
            \includegraphics[width=\linewidth]{figures/Size/WES.pdf}
            \caption{File Size Distribution in WES Data}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{File Size in WTS Data}

        \begin{figure}
            \includegraphics[width=\linewidth]{figures/Size/WTS.pdf}
            \caption{File Size Distribution in WTS Data}
        \end{figure}
    \end{frame}

    \subsubsection{Quality Checks with Coverage Depth}
    \begin{frame}
        \frametitle{Coverage Depth on WES}

        \begin{figure}
            \includegraphics[width=\linewidth]{figures/FastQC/BWA.pdf}
            \caption{Coverage Depth Plot}
        \end{figure}

        \begin{itemize}
            \item Tumor DNA: 97.6$\times$; Germline DNA: 95.8$\times$ in TCGA LUAD \cite{LUAD-1}
            \item Mean 121$\times$, with 83 \% of target bases above 30$\times$ in TCGA LUSC \cite{LUSC-1}
        \end{itemize}
    \end{frame}

    \subsubsection{Quality Checks with FastQC}
    \begin{frame}
        \frametitle{FastQC?}

        \begin{figure}
            \includegraphics[width=0.5 \linewidth]{figures/Workflow/FastQC.png}
            \caption{Example of FastQC Result \protect\cite{fastqc1}}
        \end{figure}

        \begin{itemize}
            \item A quality check tool for sequence data
            \item Give an overview that which test may be problems
        \end{itemize}
    \end{frame}

    \begin{frame}
        \frametitle{FastQC on WES}

        \begin{figure}
            \includegraphics[width=\linewidth]{figures/FastQC/FastQC_WES.pdf}
            \caption{FastQC with WES data}
        \end{figure}

        \begin{alertblock}{Failure on 33P1 sample}
            33P1 is excluded from further analyses.
        \end{alertblock}
    \end{frame}

    \begin{frame}
        \frametitle{Failure on 33P1}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/FastQC/33N.png}
                &
                \includegraphics[width=0.4 \linewidth]{figures/FastQC/33P1.png}
                \\
                \mbox{(a) 33N} & \mbox{(b) 33P1} \\
            \end{array}$
            \caption{Per Base Sequence Quality Results}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{FastQC on WTS}

        \begin{figure}
            \includegraphics[width=\linewidth]{figures/FastQC/FastQC_WTS.pdf}
            \caption{FastQC with WTS data}
        \end{figure}

        \begin{exampleblock}{All sample are good to analysis}
            $\because$ No sample has more than 5 failures.
        \end{exampleblock}
    \end{frame}

    \subsubsection{Quality Checks with Picard}
    \begin{frame}
        \frametitle{Picard?}

        \begin{figure}
            \includegraphics[width=0.5 \linewidth]{figures/CollectMultipleMetrics/12C1.quality_distribution.pdf}
            \caption{Quality Distribution of 12C1 sample}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Quality Distribution Plot}

        \begin{figure}
            \includegraphics[width=\linewidth]{figures/CollectMultipleMetrics/BWA.pdf}
            \caption{Quality Distribution by Samples}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Findings in Quality Checks}

        \begin{alertblock}{WES samples}
            \begin{itemize}
                \item 33P1 sample have not enough quality.
                \item Other samples are good to analysis.
            \end{itemize}
        \end{alertblock}

        \begin{exampleblock}{WTS samples}
            All samples are good to analysis.
        \end{exampleblock}
    \end{frame}

    \subsection{Short Nucleotide Variations Analysis}
    \begin{frame}
        \frametitle{Mutect2?}

        \begin{figure}
            \includegraphics[width=0.6 \linewidth]{figures/Workflow/somatic_short_variants.png}
            \caption{Somatic short variant discovery workflow \protect\cite{gatk1, gatk2}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{MutEnricher?}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/Workflow/MutEnricher.jpg}
            \caption{Schematic representation of MunEnricher's analysis procedures \protect\cite{MutEnricher1}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{CoMut?}

        \begin{figure}
            \includegraphics[width=\linewidth]{figures/Workflow/comut.png}
            \caption{A comutation plot generated with CoMut \protect\cite{comut1}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Driver Gene Selection Strategy}

        \begin{block}{COSMIC Cancer Gene Census \cite{CGC1}}
            Gene $\in$ CGC Tier 1 set
        \end{block}

        \begin{block}{Fisher FDR}
            Fisher FDR $ < 0.05$
        \end{block}

        \begin{block}{Fisher P-value}
            Fisher P-value $ < 0.05$
        \end{block}

        \begin{block}{Gene P-value}
            Gene P-value $ < 0.05 $
        \end{block}
    \end{frame}

    \subsubsection{Somatic Variants}
    \begin{frame}
        \frametitle{Somatic Variants in LUSC}

        \begin{figure}
            \includegraphics[width=\linewidth]{figures/Mutect2/BWA-SQC.pdf}
            \caption{CoMut Plot with LUSC Patients}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Somatic Variants in LUAD}

        \begin{figure}
            \includegraphics[width=\linewidth]{figures/Mutect2/BWA-ADC.pdf}
            \caption{CoMut Plot with LUAD Patients}
        \end{figure}
    \end{frame}

    \subsection{Mutation Shared Proportion}
    \begin{frame}
        \frametitle{Mutation Shared Proportion (MSP)?}

        \begin{block}{Mutation Shared Proportion (MSP)}
            $\textrm{MSP} = (\textrm{Precancer} \cap \textrm{Primary}) / \textrm{Primary}$
        \end{block}

        \begin{block}{Selection Strategy}
            \begin{enumerate}
                \item Non-synonymous: point mutation, frame-shift, splice site, etc.
                \item Same site: chromosome, start position \& end position
                \item Same allele: reference \& tumor allele
            \end{enumerate}
        \end{block}
    \end{frame}

    \begin{frame}
        \frametitle{Mutation Shared Proportion Distribution}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/Mutation_Shared_Proportion/Histogram/BWA.SQC.SharedProportion.pdf}
            \caption{Mutation Shared Proportion Distribution in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Mutation Shared Proportion with Clinical Data}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/Mutation_Shared_Proportion/Joint_Plot/BWA-SQC-SharedProportion/Overall Survival.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/Mutation_Shared_Proportion/Joint_Plot/BWA-SQC-SharedProportion/Recurrence-Free Survival.pdf}
                \\
                \mbox{(a) Overall Survival} & \mbox{(b) Recurrence-Free Survival} \\
            \end{array}$
            \caption{Mutation Shared Proportion with Clinical Data from LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/Mutation_Shared_Proportion/KM_Plot/BWA-SQC-SharedProportion/Overall-Survival.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/Mutation_Shared_Proportion/KM_Plot/BWA-SQC-SharedProportion/Recurrence-Free-Survival.pdf}
                \\
                \mbox{(a) Overall Survival} & \mbox{(b) Recurrence-Free Survival} \\
            \end{array}$
            \caption{K-M Survivial Plot with Median separation from LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Mutation Shared Genes}

        \begin{figure}
            \includegraphics[width=\linewidth]{figures/Mutation_Shared_Proportion/Genes/BWA.SQC.Median.pdf}
            \caption{Mutation Shared Genes with Median separation from LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Mutation Shared Genes -- Exact test}

        \begin{figure}
            \includegraphics[width=\linewidth]{figures/Mutation_Shared_Proportion/Exact/BWA-SQC.Median.pdf}
            \caption{Exact Test on Mutation Shared Genes with Median separation from LUSC}
        \end{figure}

        \begin{block}{Notable genes}
            \begin{enumerate}
                \item KMT2D
                \item NOTCH1
                \item RB1
                \item RUNX1T1
                \item TP53
            \end{enumerate}
        \end{block}

        \begin{block}{KMT2D}
            \begin{enumerate}
                \item Lysine Methyltransferase 2D
                \item KMT2D have a role in chromatin remodeling \\
                    $\Rightarrow$ transcription \& DNA repair \cite{KMT2D-3, KMT2D-4}
                \item KMT2D deficiency impairs super-enhancers \\
                    $\therefore$ To confer a glycolytic vulnerability \cite{KMT2D-1}
                \item KMT2D mutation is associated with poor prognosis in NSCLC \cite{KMT2D-2}
            \end{enumerate}
        \end{block}

        \begin{block}{NOTCH1}
            \begin{enumerate}
                \item Notch homolog protein 1
                \item NOTCH1 regulates cell-fate determination \cite{NOTCH1-1, NOTCH1-2}
                \item NOTCH1 controls epithelial--mesenchymal transition in lung cancer \cite{NOTCH1-3}
                \item Lung cancer patient has more mutations in NOTCH1 \cite{NOTCH1-4}
            \end{enumerate}
        \end{block}

        \begin{block}{RB1}
            \begin{enumerate}
                \item Retinoblastoma Transcriptional Co-repressor 1
                \item Tumor suppressor $\Leftarrow$ G1/S transition of cell cycle \cite{RB1-1}
                \item Common RB1 re-arrangements associated with histopathologic transformation \\
                in non-smoking-related lung cancer \cite{RB1-2}
                \item Nicotine \\
                    $\Rightarrow$ up-regulates FGFR3 \& RB1 expression \\
                    $\Rightarrow$ promote NSCLC cell proliferation \& EMT transition \cite{RB1-3}
                \item RB1 mutation predicts poor outcomes in NSCLC \cite{RB1-4}
            \end{enumerate}
        \end{block}

        \begin{block}{RUNX1T1}
            \begin{enumerate}
                \item RUNX1 Partner Transcriptional Co-Repressor 1
                \item RUNX1T1 facilitates transcriptional repression \\
                    $\Leftarrow$ via DNA-binding transcription factors \& histone-modifying enzymes \cite{RUNX1T1-1, RUNX1T1-2, RUNX1T1-3}
                \item RUNX1T1 has a role in SCLC \cite{RUNX1T1-4}
                \item RUNX1T1 is associated with the brain metastatic process in lung cancer \cite{RUNX1T1-5}
            \end{enumerate}
        \end{block}

        \begin{block}{TP53}
            \begin{enumerate}
                \item Tumor Protein P53
                \item TP53 mutation is associated with response \& longer survival \\
                under ICB in NSCLC \cite{TP53-1}
                \item TP53 interacts with human lung cancer microbiome \cite{TP53-2}
            \end{enumerate}
        \end{block}
        \framebreak
    \end{frame}

    \begin{frame}
        \frametitle{Findings in Mutation Sharing Proportion}
    \end{frame}

    \subsection{Copy Number Variation Analysis}
     \begin{frame}
        \frametitle{Sequenza?}

        \begin{figure}
            \includegraphics[width=0.6 \linewidth]{figures/Workflow/sequenza.jpg}
            \caption{Representative output of the Sequenza algorithm \protect\cite{sequenza1}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Cellularity \& Ploidy on WES}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/Sequenza/BWA-Sequenza-SQC.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/Sequenza/BWA-Sequenza-ADC.pdf}
                \\
                \mbox{(a) LUSC Samples} & \mbox{(b) LUAD Samples} \\
            \end{array}$
            \caption{Cellularity and Ploidy from Sequenza}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{LUSC in CNV Plot}

        \begin{figure}
            \includegraphics[width=0.6 \linewidth]{figures/Sequenza/BWA-simple-SQC.pdf}
            \caption{LUSC in CNV Plot}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/Sequenza/BWA-violin-SQC.pdf}
            \caption{LUSC in Violin Plots}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in Sequenza with LUSC}

        \begin{block}{Chr1 p-arm loss}
            \begin{enumerate}
                \item Chr1 p-arm loss in CIS compared to AAH (p $<$ 0.05).
                \item Chr1 p-arm loss in Primary compared to CIS (p $<$ 0.05).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr1 p-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr1-p.CGC-1.tex}}
            \end{table}
        \end{block}

        \begin{block}{Chr2 p-arm gain}
            \begin{enumerate}
                \item Chr2 p-arm gain in CIS compared to AAH (p $<$ 0.05).
                \item Chr2 p-arm gain in Primary compared to CIS (p $<$ 0.05).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr2 p-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr2-p.CGC-1.tex}}
            \end{table}
        \end{block}

        \begin{block}{Chr3 p-arm loss}
            \begin{enumerate}
                \item Chr3 p-arm loss in CIS compared AAH (p $<$ 1e-5).
                \item Chr3 p-arm loss in Primary compared to CIS (p $<$ 1e-5).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr3 p-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr3-p.CGC-1.tex}}
            \end{table}
        \end{block}

        \begin{block}{Chr3 q-arm gain}
            \begin{enumerate}
                \item Chr3 q-arm gain in CIS compared to AAH (p $<$ 1e-5).
                \item Chr3 q-arm gain in Primary compared to CIS (p $<$ 1e-4).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr3 q-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr3-q.CGC-1.tex}}
            \end{table}
        \end{block}

        \begin{block}{Chr4 p-arm loss}
            \begin{enumerate}
                \item Chr4 p-arm loss in CIS compared to AAH (p $<$ 0.05).
                \item Chr4 p-arm loss in Primary compared to CIS (p $<$ 0.01).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr4 p-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr4-p.CGC-1.tex}}
            \end{table}
        \end{block}

        \begin{block}{Chr4 q-arm loss}
            \begin{enumerate}
                \item Chr4 q-arm loss in CIS compared to AAH (p $<$ 0.05).
                \item Chr4 q-arm loss in Primary compared to CIS (p $<$ 0.01).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr4 q-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr4-q.CGC-1.tex}}
            \end{table}
        \end{block}

        \begin{block}{Chr5 p-arm gain}
            \begin{enumerate}
                \item Chr5 p-arm gain in CIS compared to AAH (p $<$ 0.01).
                \item Chr5 p-arm gain in Primary compared to CIS (p $<$ 0.05).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr5 p-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr5-p.CGC-1.tex}}
            \end{table}
        \end{block}

        \begin{block}{Chr5 q-arm loss}
            \begin{enumerate}
                \item Chr5 q-arm loss in CIS comparde to AAH (p $<$ 1e-5).
                \item Chr5 q-arm loss in Primary compared to CIS (p $<$ 1e-5).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Ch5 q-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr5-q.CGC-1.tex}}
            \end{table}
        \end{block}

        \begin{block}{Chr7 p-arm gain}
            \begin{enumerate}
                \item Chr7 p-arm gain in R compared to NR in CIS \& Primary (p $<$ 0.05).
                \item Chr7 p-arm gain in Primary compared to CIS (p $<$ 0.001).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr7 p-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr7-p.CGC-1.tex}}
            \end{table}
        \end{block}

        \begin{block}{Chr9 p-arm loss}
            \begin{enumerate}
                \item Chr9 p-arm loss in CIS compared to AAH (p $<$ 0.05).
                \item Chr9 p-arm loss in Primary compared to CIS (p $<$ 0.05).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr9 p-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr9-p.CGC-1.tex}}
            \end{table}
        \end{block}

        \begin{block}{Chr10 q-arm loss}
            \begin{enumerate}
                \item Chr10 q-arm loss in CIS compared to AAH (p $<$ 0.01).
                \item Chr10 q-arm loss in Primary compared to CIS (p $<$ 0.01).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr10 q-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr10-q.CGC-1.tex}}
            \end{table}
        \end{block}

        \begin{block}{Chr12 q-arm gain}
            \begin{enumerate}
                \item Chr12 p-arm gain in R compared to NR in CIS (p $<$ 0.05).
                \item Chr12 p-arm gain in Primary compared to CIS (p $<$ 0.05).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr12 p-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr12-p.CGC-1.tex}}
            \end{table}
        \end{block}

        \begin{block}{Chr13 q-arm loss}
            \begin{enumerate}
                \item Chr13 q-arm loss in CIS compared to AAH (p $<$ 0.001).
                \item Chr13 q-arm loss in Primary compared to CIS (p $<$ 0.001).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr13 q-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr13-q.CGC-1.tex}}
            \end{table}
        \end{block}

        \begin{block}{Chr20 q-arm loss}
            \begin{enumerate}
                \item Chr20 q-arm loss in CIS compared to AAH (p $<$ 0.01).
                \item Chr20 q-arm loss in Primary compared to CIS (p $<$ 0.05).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr20 q-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr20-q.CGC-1.tex}}
            \end{table}
        \end{block}

        \begin{block}{Chr21 q-arm loss}
            \begin{enumerate}
                \item Chr21 q-arm loss in CIS compared to AAH (p $<$ 0.05).
                \item Chr21 q-arm loss in Primary compared to CIS (p $<$ 0.01).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr21 q-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr21-q.CGC-1.tex}}
            \end{table}
        \end{block}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{LUAD in CNV Plot}

        \begin{figure}
            \includegraphics[width=0.6 \linewidth]{figures/Sequenza/BWA-simple-ADC.pdf}
            \caption{LUAD in CNV Plot}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/Sequenza/BWA-violin-ADC.pdf}
            \caption{LUAD in Violin Plots}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in Sequenza with LUAD}

        \begin{block}{Chr1 q-arm loss}
            \begin{enumerate}
                \item Chr1 q-arm loss in Primary compared to AIS (p $<$ 0.05).
            \end{enumerate}

            \begin{table}
                \caption{CGC Tier1 genes in Chr1 q-arm}
                \resizebox{\linewidth}{!}
                {\input{tables/GeneLocation/chr1-q.CGC-1.tex}}
            \end{table}
        \end{block}
    \end{frame}

    \begin{frame}
        \frametitle{Findings in Sequenza}
    \end{frame}

    \begin{frame}
        \frametitle{Gistic?}

        \begin{figure}
            \includegraphics[width=0.6 \linewidth]{figures/Workflow/Gistic.jpg}
            \caption{Effects of arm-level events on GISTIC results \protect\cite{gistic-1}}
        \end{figure}
    \end{frame}

    \subsubsection{Gistic in LUSC}
    \begin{frame}
        \frametitle{LUSC Data Composition}

        \begin{table}
            \caption{Number of WES samples}
            \resizebox{!}{0.3 \textheight}
            {\input{tables/WES_samples/WES_samples.tex}}
        \end{table}
    \end{frame}

    \begin{frame}
        \frametitle{Gistic in LUSC}

        \begin{figure}
            $\begin{array}{cccc}
                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/SQC-Dysplasia/amp_qplot.png}
                &
                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/SQC-CIS/amp_qplot.png}
                &
                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/SQC-Precancer/amp_qplot.png}
                &
                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/SQC-Primary/amp_qplot.png}
                \\

                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/SQC-Dysplasia/del_qplot.png}
                &
                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/SQC-CIS/del_qplot.png}
                &
                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/SQC-Precancer/del_qplot.png}
                &
                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/SQC-Primary/del_qplot.png}
                \\

                \mbox{(a) Dysplasia} & \mbox{(b) CIS} & \mbox{(c) Precancer} & \mbox{(d) Primary} \\
            \end{array}$
            \caption{Gistic results in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Peaks in LUSC}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.SQC.Amplification.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.SQC.Deletion.pdf}
                \\
                \mbox{(a) Amplification} & \mbox{(b) Deletion} \\
            \end{array}$
            \caption{Venn Diagram among Peaks in LUSC -- stage}
        \end{figure}

        \begin{table}
            \caption{Amplification Peaks in LUSC -- stage}
            \resizebox{!}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.SQC.Amplification.tex}}
        \end{table}

        \begin{table}
            \caption{Deletion Peaks in LUSC -- stage}
            \resizebox{!}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.SQC.Deletion.tex}}
        \end{table}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.SQC-simple.Amplification.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.SQC-simple.Deletion.pdf}
                \\
                \mbox{(a) Amplification} & \mbox{(b) Deletion} \\
            \end{array}$
            \caption{Venn Diagram among Peaks in LUSC -- PRE vs. PRI}
        \end{figure}

        \begin{table}
            \caption{Amplification Peaks in LUSC -- PRE vs. PRI}
            \resizebox{!}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.SQC-simple.Amplification.tex}}
        \end{table}

        \begin{table}
            \caption{Deletion Peaks in LUSC -- PRE vs. PRI}
            \resizebox{!}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.SQC-simple.Deletion.tex}}
        \end{table}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Genes in LUSC}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.SQC.Amplification.genes.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.SQC.Deletion.genes.pdf}
                \\
                \mbox{(a) Amplification} & \mbox{(b) Deletion} \\
            \end{array}$
            \caption{Venn Diagram among Genes in LUSC -- stage}
        \end{figure}

        \begin{table}
            \caption{Amplification Genes in LUSC -- stage}
            \resizebox{!}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.SQC.Amplification.genes.tex}}
        \end{table}

        \begin{table}
            \caption{Deletion Genes in LUSC -- stage}
            \resizebox{!}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.SQC.Deletion.genes.tex}}
        \end{table}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.SQC-simple.Amplification.genes.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.SQC-simple.Deletion.genes.pdf}
                \\
                \mbox{(a) Amplification} & \mbox{(b) Deletion} \\
            \end{array}$
            \caption{Venn Diagram among Genes in LUSC -- PRE vs. PRI}
        \end{figure}

        \begin{table}
            \caption{Amplification Genes in LUSC -- PRE vs. PRI}
            \resizebox{!}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.SQC-simple.Amplification.genes.tex}}
        \end{table}

        \begin{table}
            \caption{Deletion Genes in LUSC -- PRE vs. PRI}
            \resizebox{!}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.SQC-simple.Deletion.genes.tex}}
        \end{table}
    \end{frame}

    \begin{frame}
        \frametitle{Findings in LUSC Gistic Results}
    \end{frame}

    \subsubsection{Gistic in LUAD}
    \begin{frame}
        \frametitle{LUAD Data Composition}

        \begin{table}
            \caption{Number of WES samples}
            \resizebox{!}{0.3 \textheight}
            {\input{tables/WES_samples/WES_samples.tex}}
        \end{table}
    \end{frame}

    \begin{frame}
        \frametitle{Gistic in LUAD}

        \begin{figure}
            $\begin{array}{cccc}
                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/ADC-AAH/amp_qplot.png}
                &
                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/ADC-AIS/amp_qplot.png}
                &
                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/ADC-Precancer/amp_qplot.png}
                &
                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/ADC-Primary/amp_qplot.png}
                \\

                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/ADC-AAH/del_qplot.png}
                &
                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/ADC-AIS/del_qplot.png}
                &
                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/ADC-Precancer/del_qplot.png}
                &
                \includegraphics[width=0.2 \linewidth]{figures/Gistic/BWA-CNVkit/ADC-Primary/del_qplot.png}
                \\

                \mbox{(a) AAH} & \mbox{(b) AIS} & \mbox{(c) Precancer} & \mbox{(d) Primary} \\
            \end{array}$
            \caption{Gistic results in LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Peaks in LUAD}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.ADC.Amplification.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.ADC.Deletion.pdf}
                \\
                \mbox{(a) Amplification} & \mbox{(b) Deletion} \\
            \end{array}$
            \caption{Venn Diagram among Peaks in LUAD -- stage}
        \end{figure}

        \begin{table}
            \caption{Amplification Peaks in LUAD -- stage}
            \resizebox{!}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.ADC.Amplification.tex}}
        \end{table}
        \framebreak

        \begin{table}
            \caption{Deletion Peaks in LUAD -- stage}
            \resizebox{\ifdimcomp{\width}{<}{\linewidth}{\width}{\linewidth}}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.ADC.Deletion.tex}}
        \end{table}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.ADC-simple.Amplification.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.ADC-simple.Deletion.pdf}
                \\
                \mbox{(a) Amplification} & \mbox{(b) Deletion} \\
            \end{array}$
            \caption{Venn Diagram among Peaks in LUAD -- PRE vs. PRI}
        \end{figure}

        \begin{table}
            \caption{Amplification Peaks in LUAD -- PRE vs. PRI}
            \resizebox{!}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.ADC-simple.Amplification.tex}}
        \end{table}
        \framebreak

        \begin{table}
            \caption{Deletion Peaks in LUAD -- PRE vs. PRI}
            \resizebox{\ifdimcomp{\width}{<}{\linewidth}{\width}{\linewidth}}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.ADC-simple.Deletion.tex}}
        \end{table}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Genes in LUAD}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.ADC.Amplification.genes.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.ADC.Deletion.genes.pdf}
                \\
                \mbox{(a) Amplification} & \mbox{(b) Deletion} \\
            \end{array}$
            \caption{Venn Diagram among Genes in LUAD -- stage}
        \end{figure}
        \framebreak

        \begin{table}
            \caption{Amplification Genes in LUAD -- stage}
            \resizebox{!}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.ADC.Amplification.genes.tex}}
        \end{table}

        \begin{table}
            \caption{Deletion Genes in LUAD -- stage}
            \resizebox{!}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.ADC.Deletion.genes.tex}}
        \end{table}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.ADC-simple.Amplification.genes.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/Gistic/BWA-CNVkit/BWA-CNVkit.ADC-simple.Deletion.genes.pdf}
                \\
                \mbox{(a) Amplification} & \mbox{(b) Deletion} \\
            \end{array}$
            \caption{Venn Diagram among Genes in LUAD -- PRE vs. PRI}
        \end{figure}
        \framebreak

        \begin{table}
            \caption{Amplification Genes in LUAD -- PRE vs. PRI}
            \resizebox{!}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.ADC-simple.Amplification.genes.tex}}
        \end{table}
        \framebreak

        \begin{table}
            \caption{Deletion Genes in LUAD -- PRE vs. PRI}
            \resizebox{!}{\ifdimcomp{\height}{<}{0.35 \textheight}{\height}{0.35 \textheight}}
            {\input{tables/Gistic/BWA-CNVkit/BWA-CNVkit.ADC-simple.Deletion.genes.tex}}
        \end{table}
    \end{frame}

    \begin{frame}
        \frametitle{Findings in LUAD Gistic Results}
    \end{frame}

    \begin{frame}
        \frametitle{Findings in Gistic}
    \end{frame}

    \subsection{MSP vs. CNV}
    \begin{frame}
        \frametitle{CNV?}

        \begin{block}{Ploidy}
            Average copy number of chromosomes in sample (count)
        \end{block}

        \begin{block}{Region}
            Region length of CNV loss/gain (base-pair)
        \end{block}

        \begin{block}{Segment}
            Segment count of CNV loss/gain (count)
        \end{block}
    \end{frame}

    \begin{frame}
        \frametitle{Scatter Plot of MSP vs. CNV Ploidy}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/MutationSharedProportion_CNV/Ploidy/CopyNumber.BWA.Sequenza.SQC.median/Joint_All_Mutation Shared Proportion.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/MutationSharedProportion_CNV/Ploidy/CopyNumber.BWA.Sequenza.SQC.median/Joint_CIS+AIS_Mutation Shared Proportion.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/MutationSharedProportion_CNV/Ploidy/CopyNumber.BWA.Sequenza.SQC.median/Joint_Primary_Mutation Shared Proportion.pdf}
                \\
                \mbox{(a) All} & \mbox{(b) CIS} & \mbox{(c) Primary} \\
            \end{array}$
            \caption{Scatter Plot for MSP vs. CNV Ploidy}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Violin Plot of MSP vs. CNV Ploidy}

        \begin{figure}
            \includegraphics[width=0.4 \linewidth]{figures/MutationSharedProportion_CNV/Ploidy/CopyNumber.BWA.Sequenza.SQC.median/Violin_Mutation Shared Proportion.pdf}
            \caption{Violin Plot for MSP vs. CNV Ploidy}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Scatter Plot of MSP vs. CNV Region}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/MutationSharedProportion_CNV/Region/Region.BWA.Sequenza.SQC.median/Joint_All_Mutation Shared Proportion.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/MutationSharedProportion_CNV/Region/Region.BWA.Sequenza.SQC.median/Joint_CIS+AIS_Mutation Shared Proportion.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/MutationSharedProportion_CNV/Region/Region.BWA.Sequenza.SQC.median/Joint_Primary_Mutation Shared Proportion.pdf}
                \\
                \mbox{(a) All} & \mbox{(b) CIS} & \mbox{(c) Primary} \\
            \end{array}$
            \caption{Scatter Plot for MSP vs. CNV Region}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Violin Plot of MSP vs. CNV Region}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.3 \linewidth]{figures/MutationSharedProportion_CNV/Region/Region.BWA.Sequenza.SQC.median/Violin_Mutation Shared Proportion.pdf}
                &
                \includegraphics[width=0.6 \linewidth]{figures/MutationSharedProportion_CNV/Region/Region.BWA.Sequenza.SQC.median/Violin_LossGain_Mutation Shared Proportion.pdf}
                \\
                \mbox{(a) All} & \mbox{(b) Loss \& Gain} \\
            \end{array}$
            \caption{Violin Plot for MSP vs. CNV Region}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Scatter Plot of MSP vs. CNV Segment}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/MutationSharedProportion_CNV/Segment/Segment.BWA.Sequenza.SQC.median/Joint_All_Mutation Shared Proportion.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/MutationSharedProportion_CNV/Segment/Segment.BWA.Sequenza.SQC.median/Joint_CIS+AIS_Mutation Shared Proportion.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/MutationSharedProportion_CNV/Segment/Segment.BWA.Sequenza.SQC.median/Joint_Primary_Mutation Shared Proportion.pdf}
                \\
                \mbox{(a) All} & \mbox{(b) CIS} & \mbox{(c) Primary} \\
            \end{array}$
            \caption{Scatter Plot for MSP vs. CNV Segment}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Violin Plot of MSP vs. CNV Segment}

        \begin{figure}
            $\begin{array}{cc }
                \includegraphics[width=0.3 \linewidth]{figures/MutationSharedProportion_CNV/Segment/Segment.BWA.Sequenza.SQC.median/Violin_Mutation Shared Proportion.pdf}
                &
                \includegraphics[width=0.6 \linewidth]{figures/MutationSharedProportion_CNV/Segment/Segment.BWA.Sequenza.SQC.median/Violin_LossGain_Mutation Shared Proportion.pdf}
                \\
                \mbox{(a) All} & \mbox{(b) Loss \& Gain} \\
            \end{array}$
            \caption{Violin Plot for MSP vs. CNV Segment}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in MSP vs. CNV}
    \end{frame}

    \subsection{Discovery of Mutational Signature}
    \begin{frame}
        \frametitle{Mutational Signature?}

        \begin{figure}
            \includegraphics[width=0.6 \linewidth]{figures/LungCancer/signatures.jpg}
            \caption{Mutation Burdens across PCAWG tumor types \protect\cite{signature1}}
        \end{figure}
    \end{frame}

    \subsubsection{SigProfiler}
    \begin{frame}
        \frametitle{SigProfiler?}

        \begin{figure}
            \includegraphics[width=0.4 \linewidth]{figures/Workflow/SigProfiler.jpg}
            \caption{Classification of mutation signatures by SigProfiler \protect\cite{SigProfiler1, SigProfiler2, SigProfiler3}}
        \end{figure}
    \end{frame}

    \subsubsection{Single Base Substitutions (SBS)}
    \begin{frame}[allowframebreaks]
        \frametitle{SBS Signatures}

        \begin{block}{SBS1}
            \begin{itemize}
                \item An endogenous mutational process \cite{signature2}
                \item generates G$>$T mismatches in double-stranded DNA
                \item Failure $\Downarrow$ to detect \& remove these mismatches
            \end{itemize}
        \end{block}

        \begin{block}{SBS2}
            \begin{itemize}
                \item Activity of the AID/APOBEC family of cytidine deaminases \cite{signature2}
                \begin{enumerate}
                    \item APOBEC3A is probably responsible in human cancer
                    \item APOBEC3B may also contribute
                \end{enumerate}
                \item may be generated directly by DNA replication
            \end{itemize}
        \end{block}

        \begin{block}{SBS4}
            \begin{itemize}
                \item Tobacco smoking \cite{signature3}
                \item Exposed to tabacco carcinogens \textit{e.g.} benzopyrene
            \end{itemize}
        \end{block}

        \begin{block}{SBS5}
            \begin{itemize}
                \item Unknown \cite{signature3}
                \item SBS5 $\Uparrow$ in bladder cancer
                \item SBS5 $\Uparrow$ in many cancer types $\because$ Tobacco smoking
            \end{itemize}
        \end{block}

        \begin{block}{SBS10b}
            \begin{itemize}
                \item Polymerase $\epsilon$ exonuclease domain mutations \cite{signature1}
            \end{itemize}
        \end{block}

        \begin{block}{SBS13}
            \begin{itemize}
                \item Activity of the AID/APOBEC family of cytidine deaminases \cite{signature2}
                \item SBS13 is usually found with SBS2
            \end{itemize}
        \end{block}

        \begin{block}{SBS87}
            \begin{itemize}
                \item Thiopurine chemotherapy treatment \cite{signature5}
            \end{itemize}
        \end{block}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{SBS in LUSC}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.SQC.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.SQC.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS Bar Plot in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.SQC.Subtype.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.SQC.Subtype.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS Bar Plot by Cancer Subtype in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{SBS in LUSC with Smoking}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.SQC.Smoking.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.SQC.Smoking.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS Bar Plot by Cancer Subtype \& Smoking in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.SQC.Smoking.Absolute/SBS5.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.SQC.Smoking.Relative/SBS5.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS5 Signature in LUSC with Smoking}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.SQC.Smoking.Absolute/SBS10b.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.SQC.Smoking.Relative/SBS10b.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS10b Signature in LUSC with Smoking}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.SQC.Smoking.Absolute/SBS87.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.SQC.Smoking.Relative/SBS87.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS87 Signature in LUSC with Smoking}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{SBS in LUSC with Recurrence}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.SQC.Recurrence.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.SQC.Recurrence.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS Bar Plot by Cancer Subtype \& Recurrence in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.SQC.Recurrence.Absolute/SBS1.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.SQC.Recurrence.Relative/SBS1.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS1 Signature in LUSC with Recurrence}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{SBS in LUAD}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.ADC.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.ADC.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS Bar Plot in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.ADC.Subtype.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.ADC.Subtype.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS Bar Plot by Cancer Subtype in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{SBS in LUAD with Smoking}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.ADC.Smoking.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.ADC.Smoking.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS Bar Plot by Cancer Subtype \& Smoking in LUAD}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.ADC.Smoking.Absolute/SBS1.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.ADC.Smoking.Relative/SBS1.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS1 Signature in LUAD with Smoking}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.ADC.Smoking.Absolute/SBS5.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.ADC.Smoking.Relative/SBS5.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS5 Signature in LUAD with Smoking}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.ADC.Smoking.Absolute/SBS10b.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.ADC.Smoking.Relative/SBS10b.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS10b Signature in LUAD with Smoking}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.ADC.Smoking.Absolute/SBS87.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.ADC.Smoking.Relative/SBS87.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS87 Signature in LUAD with Smoking}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{SBS in LUAD with Recurrence}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.ADC.Recurrence.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-SingleBase.ADC.Recurrence.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS Bar Plot by Cancer Subtype \& Recurrence in LUAD}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.ADC.Recurrence.Absolute/SBS1.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-SingleBase.ADC.Recurrence.Relative/SBS1.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{SBS1 Signature in LUAD with Recurrence}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{SBS vs. Mutation Shared Proportion}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/CIS+AIS-SBS1.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/Primary-SBS1.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/All-SBS1.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{Shared Proportion vs. SBS1 with BWA in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/CIS+AIS-SBS2.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/Primary-SBS2.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/All-SBS2.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{Shared Proportion vs. SBS2 with BWA in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/CIS+AIS-SBS4.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/Primary-SBS4.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/All-SBS4.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{Shared Proportion vs. SBS4 with BWA in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/CIS+AIS-SBS5.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/Primary-SBS5.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/All-SBS5.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{Shared Proportion vs. SBS5 with BWA in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/CIS+AIS-SBS10b.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/Primary-SBS10b.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/All-SBS10b.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{Shared Proportion vs. SBS10b with BWA in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/CIS+AIS-SBS13.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/Primary-SBS13.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/All-SBS13.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{Shared Proportion vs. SBS13 with BWA in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/CIS+AIS-SBS87.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/Primary-SBS87.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-SBS/All-SBS87.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{Shared Proportion vs. SBS87 with BWA in LUSC}
        \end{figure}
    \end{frame}

    \subsubsection{Double Base Substitutions (DBS)}
    \begin{frame}[allowframebreaks]
        \frametitle{DBS Signatures}

        \begin{block}{DBS2}
            \begin{itemize}
                \item Tobacco smoking \cite{signature6}
                \item Other endogenous/exogenous mutagens \textit{e.g.} acetaldehyde
            \end{itemize}
        \end{block}

        \begin{block}{DBS7}
            \begin{itemize}
                \item Defective $\Downarrow$ DNA mismatch repair \cite{signature1}
            \end{itemize}
        \end{block}

        \begin{block}{DBS78A}
            \begin{itemize}
                \item Unknown
            \end{itemize}
        \end{block}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{DBS in LUSC}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-DoubleBase.SQC.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-DoubleBase.SQC.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{DBS Bar Plot in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-DoubleBase.SQC.Subtype.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-DoubleBase.SQC.Subtype.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{DBS Bar Plot by Cancer Subtype in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-DoubleBase.SQC.Subtype.Absolute/DBS2.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-DoubleBase.SQC.Subtype.Relative/DBS2.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{DBS2 Signature in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-DoubleBase.SQC.Subtype.Absolute/DBS78A.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-DoubleBase.SQC.Subtype.Relative/DBS78A.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{DBS78A Signature in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{DBS in LUSC with Smoking}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-DoubleBase.SQC.Smoking.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-DoubleBase.SQC.Smoking.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{DBS Bar Plot by Cancer Subtype \& Smoking in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-DoubleBase.SQC.Smoking.Absolute/DBS78A.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-DoubleBase.SQC.Smoking.Relative/DBS78A.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{DBS78A Signature in LUSC with Smoking}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{DBS in LUAD with Smoking}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-DoubleBase.ADC.Smoking.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-DoubleBase.ADC.Smoking.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{DBS Bar Plot by Cancer Subtype \& Smoking in LUAD}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-DoubleBase.SQC.Smoking.Absolute/DBS78A.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-DoubleBase.SQC.Smoking.Relative/DBS78A.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{DBS78A Signature in LUSC in Smoking}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{DBS in LUAD with Recurrence}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-DoubleBase.ADC.Recurrence.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-DoubleBase.ADC.Recurrence.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{DBS Bar Plot by Cancer Subtype \& Recurrence in LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{DBS vs. Mutation Shared Proportion}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-DBS/CIS+AIS-DBS2.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-DBS/Primary-DBS2.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-DBS/All-DBS2.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{Shared Proportion vs. DBS2 with BWA in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-DBS/CIS+AIS-DBS7.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-DBS/Primary-DBS7.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-DBS/All-DBS7.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{Shared Proportion vs. DBS7 with BWA in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-DBS/CIS+AIS-DBS78A.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-DBS/Primary-DBS78A.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-DBS/All-DBS78A.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{Shared Proportion vs. DBS78A with BWA in LUSC}
        \end{figure}
    \end{frame}

    \subsubsection{Short insertions \& Deletions (Indels)}
    \begin{frame}[allowframebreaks]
        \frametitle{Indel signatures}

        \begin{block}{ID83A}
            \begin{itemize}
                \item Unknown
            \end{itemize}
        \end{block}

        \begin{block}{ID83B}
            \begin{itemize}
                \item Unknown
            \end{itemize}
        \end{block}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Indels in LUSC}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.SQC.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.SQC.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{Indel Bar Plot in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.SQC.Subtype.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.SQC.Subtype.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{Indel Bar Plot by Cancer Subtype in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-Indel.SQC.Subtype.Absolute/ID83A.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-Indel.SQC.Subtype.Relative/ID83A.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{Indel83A Signature in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-Indel.SQC.Subtype.Absolute/ID83B.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-Indel.SQC.Subtype.Relative/ID83B.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{Indel83B Signature in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Indel in LUSC with Smoking}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.SQC.Smoking.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.SQC.Smoking.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{Indel Bar Plot by Cancer Subtype \& Smoking in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-Indel.SQC.Smoking.Absolute/ID83A.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-Indel.SQC.Smoking.Relative/ID83A.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{Indel83A Signature in LUSC with Smoking}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Indel in LUSC with Recurrence}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.SQC.Recurrence.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.SQC.Recurrence.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{Indel Bar Plot by Cancer Subtype \& Recurrence in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Indels in LUAD}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.ADC.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.ADC.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{Indel Bar Plot in LUAD}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.ADC.Subtype.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.ADC.Subtype.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{Indel Bar Plot by Cancer Subtype in LUAD}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-Indel.ADC.Subtype.Absolute/ID83A.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-Indel.ADC.Subtype.Relative/ID83A.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{Indel83A Signature in LUAD}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-Indel.ADC.Subtype.Absolute/ID83B.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Violin/COSMIC-Indel.ADC.Subtype.Relative/ID83B.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{Indel83B Signature in LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Indel in LUAD with Smoking}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.ADC.Smoking.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.ADC.Smoking.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{Indel Bar Plot by Cancer Subtype \& Smoking in LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Indel in LUAD with Recurrence}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.ADC.Recurrence.Absolute.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/SigProfiler/BWA-Bar/COSMIC-Indel.ADC.Recurrence.Relative.pdf}
                \\
                \mbox{(a) Absolute} & \mbox{(b) Relative} \\
            \end{array}$
            \caption{Indel Bar Plot by Cancer Subtype \& Recurrence in LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Indel vs. Mutation Shared Proportion}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-Indel/CIS+AIS-ID83A.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-Indel/Primary-ID83A.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-Indel/All-ID83A.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{Shared Proportion vs. ID83A with BWA in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-Indel/CIS+AIS-ID83B.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-Indel/Primary-ID83B.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/Mutation_Shared_Proportion/Signature/SigProfiler/BWA-SQC-Indel/All-ID83B.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{Shared Proportion vs. ID83B with BWA in LUSC}
        \end{figure}
    \end{frame}

    \subsubsection{Mutational Signatures vs. Clinical Data}
    \begin{frame}[allowframebreaks]
        \frametitle{Mutational Signatures vs. Overall Survival -- SBS}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/CIS+AIS-SBS1.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/Primary-SBS1.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/All-SBS1.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS1 vs. Overall Survival in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/CIS+AIS-SBS2.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/Primary-SBS2.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/All-SBS2.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS2 vs. Overall Survival in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/CIS+AIS-SBS4.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/Primary-SBS4.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/All-SBS4.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS4 vs. Overall Survival in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/CIS+AIS-SBS5.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/Primary-SBS5.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/All-SBS5.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS5 vs. Overall Survival in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/CIS+AIS-SBS10b.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/Primary-SBS10b.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/All-SBS10b.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS10b vs. Overall Survival in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/CIS+AIS-SBS13.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/Primary-SBS13.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/All-SBS13.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS13 vs. Overall Survival in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/CIS+AIS-SBS87.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/Primary-SBS87.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-OS_SBS/All-SBS87.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS87 vs. Overall Survival in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Mutational Signatures vs. Recurrence-Free Survival}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/CIS+AIS-SBS1.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/Primary-SBS1.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/All-SBS1.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS1 vs. Recurrence-Free Survival in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/CIS+AIS-SBS2.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/Primary-SBS2.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/All-SBS2.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS2 vs. Recurrence-Free Survival in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/CIS+AIS-SBS4.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/Primary-SBS4.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/All-SBS4.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS4 vs. Recurrence-Free Survival in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/CIS+AIS-SBS5.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/Primary-SBS5.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/All-SBS5.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS5 vs. Recurrence-Free Survival in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/CIS+AIS-SBS10b.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/Primary-SBS10b.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/All-SBS10b.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS10b vs. Recurrence-Free Survival in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/CIS+AIS-SBS13.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/Primary-SBS13.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/All-SBS13.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS13 vs. Recurrence-Free Survival in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/CIS+AIS-SBS87.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/Primary-SBS87.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-RFS_SBS/All-SBS87.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS87 vs. Recurrence-Free Survival in LUSC}
        \end{figure}

    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Mutational Signatures vs. Volume Doubling Time}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/CIS+AIS-SBS1.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/Primary-SBS1.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/All-SBS1.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS1 vs. Volume Doubling Time in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/CIS+AIS-SBS2.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/Primary-SBS2.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/All-SBS2.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS2 vs. Volume Doubling Time in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/CIS+AIS-SBS4.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/Primary-SBS4.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/All-SBS4.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS4 vs. Volume Doubling Time in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/CIS+AIS-SBS5.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/Primary-SBS5.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/All-SBS5.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS5 vs. Volume Doubling Time in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/CIS+AIS-SBS10b.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/Primary-SBS10b.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/All-SBS10b.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS10b vs. Volume Doubling Time in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/CIS+AIS-SBS13.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/Primary-SBS13.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/All-SBS13.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS13 vs. Volume Doubling Time in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/CIS+AIS-SBS87.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/Primary-SBS87.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/SigProfiler_Clinical/BWA-SQC-VDT_SBS/All-SBS87.pdf}
                \\
                \mbox{(a) CIS} & \mbox{(b) Primary} & \mbox{(c) All} \\
            \end{array}$
            \caption{SBS87 vs. Volume Doubling Time in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Findings in Mutation Signature}
    \end{frame}

    \subsection{Differences in Gene Expression Levels}
    \begin{frame}
        \frametitle{RSEM?}

        \begin{figure}
            \includegraphics[width=0.2 \linewidth]{figures/Workflow/RSEM.jpg}
            \caption{RSEM workflow \protect\cite{RSEM1}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{DESeq2?}

        \begin{figure}
            \includegraphics[width=0.5 \linewidth]{figures/Workflow/DESeq2.png}
            \caption{DESeq2 workflow \protect\cite{DESeq1}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{DEG Selection Strategy}
        DEG: differentially expressed genes

        \begin{block}{Fold Change}
            $\log_{2}(\text{Fold Change}) > 1 \vee \log_{2}(\text{Fold Change}) < -1$
        \end{block}

        \begin{block}{P-value}
            $\text{P-value} < 0.05$
        \end{block}

        \begin{block}{Adjusted P-value}
            $\text{Padj} < 0.05$
        \end{block}
    \end{frame}

    \begin{frame}
        \frametitle{Enrichr?}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/Workflow/Enrichr.jpg}
            \caption{Enrichr workflow \protect\cite{Enrichr1, Enrichr2}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Gene-set Library}

        \begin{figure}
            \includegraphics[width=0.6 \linewidth]{figures/Workflow/KEGG.jpg}
            \caption{The global map of metabolic pathways by KEGG \protect\cite{KEGG1}}
        \end{figure}

        \begin{block}{KEGG}
            KEGG 2021 Human
        \end{block}
    \end{frame}

    \begin{frame}
        \frametitle{WTS Data Composition}

        \begin{table}
            \caption{Number of WTS samples}
            \input{tables/WTS_samples/WTS_samples.tex}
        \end{table}
    \end{frame}

    \subsubsection{Comparing Cancer Stages in LUSC}
    \begin{frame}
        \frametitle{DEG Heatmap in LUSC}

        \begin{figure}
            \includegraphics[width=0.35 \linewidth]{figures/DEG/Cluster/STAR.FPKM.SQC.pdf}
            \caption{DEG FPKM Heatmap of LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{DEG Volcano Plots in LUSC}
        LUSC: Normal $\rightarrow$ Dysplasia $\rightarrow$ CIS $\rightarrow$ Primary

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.2 \linewidth]{figures/DEG/Volcano/STAR.FPKM.SQC.Normal-Dysplasia.volcano.pdf}
                &
                \includegraphics[width=0.2 \linewidth]{figures/DEG/Volcano/STAR.FPKM.SQC.Normal-CIS.volcano.pdf}
                &
                \includegraphics[width=0.2 \linewidth]{figures/DEG/Volcano/STAR.FPKM.SQC.Normal-Primary.volcano.pdf}
                \\
                \mbox{(a) Normal-Dysplasia} & \mbox{(b) Normal-CIS} & \mbox{(c) Normal-Primary} \\

                \includegraphics[width=0.2 \linewidth]{figures/DEG/Volcano/STAR.FPKM.SQC.Dysplasia-CIS.volcano.pdf}
                &
                \includegraphics[width=0.2 \linewidth]{figures/DEG/Volcano/STAR.FPKM.SQC.Dysplasia-Primary.volcano.pdf}
                &
                \includegraphics[width=0.2 \linewidth]{figures/DEG/Volcano/STAR.FPKM.SQC.CIS-Primary.volcano.pdf}
                \\
                \mbox{(d) Dysplasia-CIS} & \mbox{(e) Dysplasia-Primary} & \mbox{(f) CIS-Primary} \\
            \end{array}$
            \caption{DEG Volcano Plots in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Violin Plots in LUSC}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/BCL2L12.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/HMGA2.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/MSH6.pdf}
                \\
                \mbox{(a) BCL2L12} & \mbox{(b) HMGA2} & \mbox{(c) MSH6} \\
            \end{array}$
            \caption{Up-regulated genes in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/PABPC1.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/PPP2R1A.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/TP63.pdf}
                \\
                \mbox{(d) PABPC1} & \mbox{(e) PPP2R1A} & \mbox{(f) TP63} \\
            \end{array}$
            \caption{Up-regulated genes in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/CACNA1D.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/ELN.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/ESR1.pdf}
                \\
                \mbox{(a) CACNA1D} & \mbox{(b) ELN} & \mbox{(c) ESR1} \\
            \end{array}$
            \caption{Down-regulated genes in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/IL6ST.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/NTRK3.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/PER1.pdf}
                \\
                \mbox{(d) IL6ST} & \mbox{(e) NTRK3} & \mbox{(f) PER1} \\
            \end{array}$
            \caption{Down-regulated genes in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/PPARG.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/PTPRB.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/TNFRSF14.pdf}
                \\
                \mbox{(g) PPARG} & \mbox{(h) PTPRB} & \mbox{(i) TNFRSF14} \\
            \end{array}$
            \caption{Down-regulated genes in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{c}
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.violin/ZNF331.pdf}
                \\
                \mbox{(j) ZNF331} \\
            \end{array}$
            \caption{Down-regulated genes in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{DEG Upset Plots in LUSC}
        LUSC: Normal $\rightarrow$ Dysplasia $\rightarrow$ CIS $\rightarrow$ Primary

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Pair-Venn/STAR.FPKM.SQC.Up.venn.pdf}
            \caption{Up-regulated genes in LUSC}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Pair-Venn/STAR.FPKM.SQC.Down.venn.pdf}
            \caption{Down-regulated genes in LUSC}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Pair-Venn/STAR.FPKM.SQC.venn.pdf}
            \caption{Upset plot in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Enrichment tests with Normal vs. Dysplasia in LUSC}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.SQC.Normal-Dysplasia.Up.KEGG.pdf}
            \caption{Up-regulated Pathways on Normal vs. Dysplasia}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.SQC.Normal-Dysplasia.Down.KEGG.pdf}
            \caption{Down-regulated Pathways on Normal vs. Dysplasia}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Enrichment tests with Normal vs. CIS in LUSC}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.SQC.Normal-CIS.Up.KEGG.pdf}
            \caption{Up-regulated Pathways on Normal vs. CIS}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.SQC.Normal-CIS.Down.KEGG.pdf}
            \caption{Down-regulated Pathways on Normal vs. CIS}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Enrichment tests with Normal vs. Primary in LUSC}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.SQC.Normal-Primary.Up.KEGG.pdf}
            \caption{Up-regulated Pathways on Normal vs. Primary}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.SQC.Normal-Primary.Down.KEGG.pdf}
            \caption{Down-regulated Pathways on Normal vs. Primary}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in Comparing cancer stage in LUSC}

        \begin{block}{BCL2L12}
            \begin{enumerate}
                \item Up-regulated in CIS compared to Normal.
                \item Up-regulated in Primary compared to CIS.
                \item BCL2-Like 12
                \item Prognostic biomarker for many cancers
                \begin{itemize}
                    \item breast cancer \cite{BCL2L12-1, BCL2L12-4}
                    \item laryngeal cancer \cite{BCL2L12-2}
                    \item colon cancer \cite{BCL2L12-3}
                \end{itemize}
            \end{enumerate}
        \end{block}

        \begin{block}{HMGA2}
            \begin{enumerate}
                \item Up-regulated in CIS compared to Normal.
                \item Up-regulated in Primary compared to CIS.
                \item High Mobility Group AT-Hook 2
                \item Cell cycle regulation through CCNA2 \cite{HMGA2-1, HMGA2-4}.
                \item Over-expression in NSCLC \cite{HMGA2-2}.
                \item Regulates lung cancer proliferation \& metastasis \cite{HMGA2-3}.
            \end{enumerate}
        \end{block}

        \begin{block}{MSH6}
            \begin{enumerate}
                \item Up-regulated in CIS compared to Normal.
                \item Up-regulated in Primary compared to CIS.
                \item DNA (G/T) mismatch repair protein: mutS homolog 6
                \item Recognizes single-base mismatch in DNA \cite{MSH6-1}.
                \item Prevalence MSH5 mutations in East Asian NSCLC \cite{MSH6-2}.
                \item MSH6 mutation in co-occurrence of NSCLC and thyroid cancer \cite{MSH6-3}.
            \end{enumerate}
        \end{block}

        \begin{block}{PABPC1}
            \begin{enumerate}
                \item Up-regulated in CIS compared to Normal.
                \item Up-regulated in Primary compared to CIS.
                \item Poly-A Binding Protein Cytoplasmic 1
                \item Regulates mRNA metabolism processes  \cite{PABPC1-1} \\
                    e.g. pre-mRNA splicing \& mRNA stability.
                \item Inactivation of MKRN3 $\Rightarrow$ Over-expression of PABPC1 \\
                    $\therefore$ Accelerates NSCLC tumorigenesis \cite{PABPC1-2}.
                \item Over-expression in NSCLC \cite{PABPC1-3}.
            \end{enumerate}
        \end{block}

        \begin{block}{PPP2R1A}
            \begin{enumerate}
               \item Up-regulated in CIS compared to Normal.
               \item Up-regulated in Primary compared to CIS.
               \item Protein Phosphatase 2 Scaffold Sub-unit A, alpha isoform
               \item Inhibitor of serine/threonine-protein phosphatase 2A (PP2A) \cite{PPP2R1A-1, PPP2R1A-2}.
               \item 6.7 \% of SCLC patients harbored PPP2R1A mutation \cite{PPP2R1A-3}.
               \item AMOTL2 inhibits PPP2R2A $\Rightarrow$ Suppress proliferation of NSCLC \cite{PPP2R1A-4}.
            \end{enumerate}
        \end{block}

        \begin{block}{TP63}
            \begin{enumerate}
                \item Up-regulated in CIS compared to Normal.
                \item Up-regulated in Primary compared to CIS.
                \item Tumor Protein P63
                \item Required in conjunction with TP73 for TP53-dependent apoptosis \cite{TP63-1, TP63-2}.
                \item 2.02 \% (25/1236) NSCLC patients harbored TP63 mutation \cite{TP63-3} \\
                    $\therefore$ TP63 as prognostic and predictive biomarker.
                \item TP63 over-expression have a strong negative impact on LUAD \& LUSC \cite{TP63-4}.
            \end{enumerate}
        \end{block}

        \begin{block}{CACNA1D}
            \begin{enumerate}
                \item Down-regulated in CIS compared to Normal.
                \item Down-regulated in Primary compared to CIS.
                \item Calcium Voltage-Gated Channel Sub-unit Alpha-1D
                \item Involved in a variety of calcium-dependent processes \cite{CACNA1D-1} \\
                    e.g. muscle contraction, gene expression, cell division, and cell death
                \item CACNA1D under-expression in tumorigenesis \& progression of LUAD \cite{CACNA1D-2}.
            \end{enumerate}
        \end{block}

        \begin{block}{ELN}
            \begin{enumerate}
                \item Down-regulated in CIS compared to Normal.
                \item Down-regulated in Primary compared to CIS.
                \item Elastin
            \end{enumerate}
        \end{block}

        \begin{block}{ESR1}
            \begin{enumerate}
                \item Down-regulated in CIS compared to Normal.
                \item Down-regulated in Primary compared to CIS.
                \item Estrogen Receptor 1
                \item Nuclear hormone receptor that affects cellular proliferation \& differentiation \cite{ESR1-1}.
                \item Low expression of ESR1/PGR correlates with poor survival in TCGA \cite{ESR1-2}.
                \item CHRNA5 increasing $\Rightarrow$ ESR1 down-regulation \\
                    $\therefore$ Worse prognosis in breast cancer \cite{ESR1-3}.
            \end{enumerate}
        \end{block}

        \begin{block}{IL6ST}
            \begin{enumerate}
                \item Down-regulated in CIS compared to Normal.
                \item Down-regulated in Primary compared to CIS.
                \item Interleukin-5 Receptor Sub-unit beta
                \item Signal-transducing molecule of receptor systems e.g. IL6 \cite{IL6ST-1}.
                \item IL6ST has a critical role for miR-188-5p in breast cancer \cite{IL6ST-2}.
            \end{enumerate}
        \end{block}

        \begin{block}{NTRK3}
            \begin{enumerate}
                \item Down-regulated in CIS compared to Normal.
                \item Down-regulated in Primary compared to CIS.
                \item Neurotrophic Receptor Tyrosine Kinase 3
                \item Involved in nervous system \& heart development \cite{NTRK3-1}.
                \item NTRK3-mutation predict the prognosis of LUAD with ICI treatment \cite{NTRK3-2}.
                \item 5.76-fold down-regulation in breast cancer \cite{NTRK3-3}.
            \end{enumerate}
        \end{block}

        \begin{block}{PER1}
            \begin{enumerate}
                \item Down-regulated in CIS compared to Normal.
                \item Down-regulated in Primary compared to CIS.
                \item Period Circadian Regulator 1
                \item Transcriptional repressor: a core components of circadian clock \cite{PER1-1}.
                \item Less expression of PER1 had shorter survival in NSCLC \cite{PER1-2}.
                \item Loss of PER1 was correlated with clinical values \cite{PER1-3}:
                \begin{itemize}
                    \item Poor differentiation (p $<$ 0.001)
                    \item Tumor status (p $<$ 0.05)
                    \item High p-TNM stage (p $<$ 0.001)
                \end{itemize}
            \end{enumerate}
        \end{block}

        \begin{block}{PPARG}
            \begin{enumerate}
                \item Down-regulated in CIS compared to Normal.
                \item Down-regulated in Primary compared to CIS.
                \item Peroxisome Proliferator Activated Receptor gamma
                \item Nuclear receptor modulates transcription of target genes \cite{PPARG-1} \\
                    e.g. acyl-CoA oxidase
                \item PPARG $\Downarrow$ $\Rightarrow$ Anti-fibrotic miRNA network in Liver \\
                    $\Downarrow$ $\Rightarrow$ Tumor development $\Uparrow$ \cite{PPARG-2}.
            \end{enumerate}
        \end{block}

        \begin{block}{PTPRB}
            \begin{enumerate}
                \item Down-regulated in CIS compared to Normal.
                \item Down-regulated in Primary compared to CIS.
                \item Protein Tyrosine Phosphatase Receptor Type B
                \item Blood vessel remodeling \& Angiogenesis \cite{PTPRB-1}.
                \item PTPRB $\Downarrow$ $\Rightarrow$ miR-665 $\Uparrow$ $\Rightarrow$ Promotes \cite{PTPRB-2, PTPRB-3}:
                \begin{itemize}
                    \item Hepatocelluar carcinoma cell proliferation
                    \item Hepatocelluar carcinoma cell migration
                    \item Hepatocelluar carcinoma cell invasion
                \end{itemize}
            \end{enumerate}
        \end{block}

        \begin{block}{TNFRSF14}
            \begin{enumerate}
                \item Down-regulated in CIS compared to Normal.
                \item Down-regulated in Primary compared to CIS.
                \item TNF Receptor Super-family Member 14
                \item Defining a complex stimulatory \& signaling network \cite{TNFRSF14-1}.
                \item TNFRSF14 silencing increases migration \& invasiveness of endometrial carcinoma \\
                    by promoting epithelial-mesenchymal transition \cite{TNFRSF14-2}.
                \item TNFRSF14 is negatively correlative gene with prognosis in LUAD \cite{TNFRSF14-3}.
            \end{enumerate}
        \end{block}

        \begin{block}{ZNF331}
            \begin{enumerate}
                \item Down-regulated in CIS compared to Normal.
                \item Down-regulated in Primary compared to CIS.
                \item Zinc Finger Protein 331
                \item ZNF331 methylation affect gastric cancer risk \cite{ZNF331-1}.
                \item Suppressing tumor growth \& Invasiveness of gastric cancer cells \cite{ZNF331-2}.
            \end{enumerate}
        \end{block}
    \end{frame}

    \subsubsection{Comparing Cancer Stages in LUAD}
    \begin{frame}
        \frametitle{DEG Heatmap in LUAD}

        \begin{figure}
            \includegraphics[width=0.35 \linewidth]{figures/DEG/Cluster/STAR.FPKM.ADC.pdf}
            \caption{DEG FPKM Heatmap of LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{DEG Volcano Plots in LUAD}
        LUAD: Normal $\rightarrow$ AAH $\rightarrow$ AIS $\rightarrow$ Primary

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.2 \linewidth]{figures/DEG/Volcano/STAR.FPKM.ADC.Normal-AAH.volcano.pdf}
                &
                \includegraphics[width=0.2 \linewidth]{figures/DEG/Volcano/STAR.FPKM.ADC.Normal-AIS.volcano.pdf}
                &
                \includegraphics[width=0.2 \linewidth]{figures/DEG/Volcano/STAR.FPKM.ADC.Normal-Primary.volcano.pdf}
                \\
                \mbox{(a) Normal-AAH} & \mbox{(b) Normal-AIS} & \mbox{(c) Normal-Primary} \\

                \includegraphics[width=0.2 \linewidth]{figures/DEG/Volcano/STAR.FPKM.ADC.AAH-AIS.volcano.pdf}
                &
                \includegraphics[width=0.2 \linewidth]{figures/DEG/Volcano/STAR.FPKM.ADC.AAH-Primary.volcano.pdf}
                &
                \includegraphics[width=0.2 \linewidth]{figures/DEG/Volcano/STAR.FPKM.ADC.AIS-Primary.volcano.pdf}
                \\
                \mbox{(d) AAH-AIS} & \mbox{(e) AAH-Primary} & \mbox{(f) AIS-Primary} \\
            \end{array}$
            \caption{DEG Volcano Plots in LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Violin Plots in LUAD}

        \begin{figure}
            $\begin{array}{c}
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.ADC.violin/MUC1.pdf}
                \\
                \mbox{(a) MUC1} \\
            \end{array}$
            \caption{Up-regulated genes in LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{DEG Upset Plots in LUAD}
        LUAD: Normal $\rightarrow$ AAH $\rightarrow$ AIS $\rightarrow$ Primary

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Pair-Venn/STAR.FPKM.ADC.Up.venn.pdf}
            \caption{Up-regulated genes in LUAD}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Pair-Venn/STAR.FPKM.ADC.Down.venn.pdf}
            \caption{Down-regulated genes in LUAD}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Pair-Venn/STAR.FPKM.ADC.venn.pdf}
            \caption{Upset Plot in LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Enrichment tests with Normal vs. AAH in LUAD}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.ADC.Normal-AAH.Up.KEGG.pdf}
            \caption{Up-regulated Pathways on Normal vs. AAH}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.ADC.Normal-AAH.Down.KEGG.pdf}
            \caption{Down-regulated Pathways on Normal vs. AAH}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Enrichment tests with Normal vs. AIS in LUAD}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.ADC.Normal-AIS.Up.KEGG.pdf}
            \caption{Up-regulated Pathways on Normal vs. AIS}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.ADC.Normal-AIS.Down.KEGG.pdf}
            \caption{Down-regulated Pathways on Normal vs. AIS}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Enrichment tests with Normal vs. Primary in LUAD}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.ADC.Normal-Primary.Up.KEGG.pdf}
            \caption{Up-regulated Pathways on Normal vs. Primary}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.ADC.Normal-Primary.Down.KEGG.pdf}
            \caption{Down-regulated Pathways on Normal vs. Primary}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Finding in Comparing cancer stage in LUAD}

        \begin{block}{MUC1}
            \begin{enumerate}
                \item Down-regulated in Normal $\Rightarrow$ AIS $\Rightarrow$ Primary.
            \end{enumerate}
        \end{block}
    \end{frame}

    \subsubsection{Mutation Shared Proportion in LUSC}
    \begin{frame}[allowframebreaks]
        \frametitle{Mutation Shared Proportion Distribution}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/Mutation_Shared_Proportion/Histogram/BWA.SQC.SharedProportion.pdf}
            \caption{Mutation Shared Proportion (MSP) Distribution in LUSC}
        \end{figure}

        \begin{block}{Summary}
            \begin{itemize}
                \item Minimum: 0
                \item Mean: 0.132
                \item Median: 0.081
                \item Maximum: 0.525
            \end{itemize}
        \end{block}

        \begin{exampleblock}{MSP Lower/Higher}
            By median (appr. 8 \%), MSP Lower/Higher are classified.
        \end{exampleblock}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{DEG Heatmap with MSP in LUSC}

        \begin{figure}
            \includegraphics[width=0.35 \linewidth]{figures/DEG/Cluster/STAR.FPKM.SQC.MSP-Median.pdf}
            \caption{DEG FPKM Heatmap with MSP in LUSC}
        \end{figure}
        \framebreak

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Cluster/STAR.FPKM.SQC.Normal.MSP-Median.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Cluster/STAR.FPKM.SQC.CIS.MSP-Median.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Cluster/STAR.FPKM.SQC.Primary.MSP-Median.pdf}
                \\
                \mbox{(a) Normal} & \mbox{(b) CIS} & \mbox{(c) Primary} \\
            \end{array}$
            \caption{DEG FPKM Heatmap by Stages with MSP in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{DEG Volcano Plots with MSP in LUSC}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Volcano/STAR.FPKM.SQC.Normal.MSP-Median.volcano.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Volcano/STAR.FPKM.SQC.CIS.MSP-Median.volcano.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Volcano/STAR.FPKM.SQC.Primary.MSP-Median.volcano.pdf}
                \\
                \mbox{(a) Normal} & \mbox{(b) CIS} & \mbox{(c) Primary} \\
            \end{array}$
            \caption{DEG Volcano Plots with MSP in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Violin Plots with MSP in LUSC}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.MSP-Median.violin/Mutation Shared Proportion_BRD4.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.MSP-Median.violin/Mutation Shared Proportion_EIF4A2.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.MSP-Median.violin/Mutation Shared Proportion_FEN1.pdf}
                \\
                \mbox{(a) BRD4} & \mbox{(b) EIF4A2} & \mbox{(c) FEN1} \\
            \end{array}$
            \caption{Up-regulated genes with MSP in CIS of LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.MSP-Median.violin/Mutation Shared Proportion_PCBP1.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.MSP-Median.violin/Mutation Shared Proportion_SDHA.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.MSP-Median.violin/Mutation Shared Proportion_TRIM33.pdf}
                \\
                \mbox{(d) PCBP1}  & \mbox{(e) SDHA} & \mbox{(f) TRIM33} \\
            \end{array}$
            \caption{Up-regulated genes with MSP in CIS of LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.MSP-Median.violin/Mutation Shared Proportion_CCR7.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.MSP-Median.violin/Mutation Shared Proportion_CRTC3.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.MSP-Median.violin/Mutation Shared Proportion_KAT7.pdf}
                \\
                \mbox{(a) CCR7} & \mbox{(b) CRTC3} & \mbox{(c) KAT7} \\
            \end{array}$
            \caption{Down-regulated genes with MSP in CIS of LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.MSP-Median.violin/Mutation Shared Proportion_KMT2A.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/DEG/Violin/STAR.FPKM.SQC.MSP-Median.violin/Mutation Shared Proportion_NCOA2.pdf}
                \\
                \mbox{(d) KMT2A} & \mbox{(e) NCOA2} \\
            \end{array}$
            \caption{Down-regulated genes with MSP in CIS of LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{DEG Upset Plots with MSP in LUSC}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Pair-Venn/STAR.FPKM.SQC.MSP-Median.Up.venn.pdf}
            \caption{Up-regulated genes with MSP in LUSC}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/DEG/Pair-Venn/STAR.FPKM.SQC.MSP-Median.Down.venn.pdf}
            \caption{Down-regulated genes with MSP in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Enrichment tests with MSP in LUSC}

        \begin{figure}
            \includegraphics[width=0.7 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.SQC.MSP-Median.Up.KEGG.pdf}
            \caption{Up-regulated Pathways with MSP in LUSC}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.7 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.SQC.MSP-Median.Down.KEGG.pdf}
            \caption{Down-regulated Pathways with MSP in LUSC}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.7 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.SQC.Normal.MSP-Median.Up.KEGG.pdf}
            \caption{Up-regulated Pathways with MSP in Normal}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.7 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.SQC.Normal.MSP-Median.Down.KEGG.pdf}
            \caption{Down-regulated Pathways with MSP in Normal}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.7 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.SQC.CIS.MSP-Median.Up.KEGG.pdf}
            \caption{Up-regulated Pathways with MSP in CIS}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.7 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.SQC.CIS.MSP-Median.Down.KEGG.pdf}
            \caption{Down-regulated Pathways with MSP in CIS}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.7 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.SQC.Primary.MSP-Median.Up.KEGG.pdf}
            \caption{Up-regulated Pathways with MSP in Primary}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.7 \linewidth]{figures/DEG/Enrichment/STAR.FPKM.SQC.Primary.MSP-Median.Down.KEGG.pdf}
            \caption{Down-regulated Pathways with MSP in Primary}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in Comparing MSP in LUSC}

        \begin{block}{BRD4}
            \begin{enumerate}
                \item Up-regulated in CIS of MSP-higher compared to MSP-lower.
                \item Bronmodomain Containing 4
                \item Role in transmission of epigenetic memory across cell division \& transcription regulation \cite{BRD4-1}.
                \item microRNA-4651 targets BRD4 \\
                    $\therefore$ Inhibition of NSCLC progression \cite{BRD4-2}.
                \item Resistance to BET inhibitor in LUAD is mediated by BRD4 \cite{BRD4-3}.
            \end{enumerate}
        \end{block}

         \begin{block}{EIF4A2}
            \begin{enumerate}
                \item Up-regulated in CIS of MSP-higher compared to MSP-lower.
                \item Eukaryotic Translation Initiation Factor 4A2
                \item EIF4A2 is higher in tumor tissue and predicts poor prognosis in colorectal cancer \cite{EIF4A2-1}.
                \item EIF4A2 high expression are associated with a poor prognosis in esophageal squamous cell carcinoma \cite{EIF4A2-2}.
            \end{enumerate}
        \end{block}

         \begin{block}{FEN1}
            \begin{enumerate}
                \item Up-regulated in CIS of MSP-higher compared to MSP-lower.
                \item Flap Structure-Specific Endonuclease 1
                \item Involved in DNA replication and repair \cite{FEN1-1}.
                \item Over-expression of FEN1 correlates with enhanced proliferation \& poor prognosis in NSCLC \cite{FEN1-2}.
                \item PRMT1 maintains high expression of FEN1 \\
                    $\Rightarrow$ DNA repair ability \& Drug resistance of lung cancer \cite{FEN1-3}.
            \end{enumerate}
        \end{block}

         \begin{block}{PCBP1}
            \begin{enumerate}
                \item Up-regulated in CIS of MSP-higher compared to MSP-lower.
                \item Poly(RC) Binding Protein 1
                \item Regulates mRNA splicing \cite{PCBP1-1}.
                \item PCBP1 is distinctive tumor suppressor \cite{PCBP1-2} ??
                \item PCBP1 represses LUAD progression \cite{PCBP1-3} ??
            \end{enumerate}
        \end{block}

         \begin{block}{SDHA}
            \begin{enumerate}
                \item Up-regulated in CIS of MSP-higher compared to MSP-lower.
                \item Succinate Dehydrogenase complex flavoprotein sub-unit A
                \item Mitochondrial electron transport \cite{SDHA-1}.
                \item SDHA promote tumorigenesis in kidney cancer \cite{SDHA-2}.
                \item Over-expression of mitochondria pathway including SDHA in LUAD \& LUSC \cite{SDHA-3}.
            \end{enumerate}
        \end{block}

         \begin{block}{TRIM33}
            \begin{enumerate}
                \item Up-regulated in CIS of MSP-higher compared to MSP-lower.
                \item Tripartite Motif containing 33
                \item Acts as an E3 ubiquitin-protein ligase \cite{TRIM33-1}.
                \item Down-regulation of TRIM33 promotes proliferation in gastric cancer \cite{TRIM33-2} ??
                \item TRIM33 inhibition in metastasis of oral squamous cell carcinoma \cite{TRIM33-3} ??
            \end{enumerate}
        \end{block}

         \begin{block}{CCR7}
            \begin{enumerate}
                \item Down-regulated in CIS of MSP-higher compared to MSP-lower.
                \item C-C motif Chemokine Receptor 7
                \item Mediator of EBV effects on B-cell \cite{CCR7-1}.
                \item Key role in activation of T-cell, B-cell, and dendritic cells \cite{CCR7-2}.
            \end{enumerate}
        \end{block}

        \begin{block}{CRTC3}
            \begin{enumerate}
                \item Down-regulated in CIS of MSP-higher compared to MSP-lower.
                \item CREB Regulated Transcription Co-activator 3
                \item Transcriptional co-activator for CREB1 \cite{CRTC3-1}.
                \item CRTC2 promote tumorigenesis in LKB1-mutant NSCLC \cite{CRTC3-2} ??
            \end{enumerate}
        \end{block}

        \begin{block}{KAT7}
            \begin{enumerate}
                \item Down-regulated in CIS of MSP-higher compared to MSP-lower.
                \item K (Lysine) Acetyltransferase 7
                \item Regulates various processes, e.g. gene transcription, immune regulation \cite{KAT7-1}.
                \item UHRF1 is associated with KAT7 $\Rightarrow$ Negatively regulates KAT7-mediated H3K14 acetylation \\
                    $\therefore$ Suppression of colon cancer cell proliferation \cite{KAT7-2}
                \item Long non-coding RNA-KAT7 is negatively associated with \cite{KAT7-3}:
                \begin{itemize}
                    \item tumor size
                    \item tumor differentiation
                    \item lymph node metastasis
                \end{itemize}
            \end{enumerate}
        \end{block}

        \begin{block}{KMT2A}
            \begin{enumerate}
                \item Down-regulated in Normal \& CIS of MSP-higher compared to MSP-lower.
                \item K (Lysine) Methyltransferase 2A
                \item Essential role in early development and hematopoiesis \cite{KMT2A-1, KMT2A-2}.
                \item KMT2A is frequently mutated in leukemia \cite{KMT2A-3, KMT2A-4}.
                \item Rearrangement on KMT2A is associated with worse outcome in acute myeloid leukemia \cite{KMT2A-6}.
                \item KMT2A is frequently mutated in NSCLC, associated with higher TMB \& PD-L1 expression \cite{KMT2A-5}.
            \end{enumerate}
        \end{block}

         \begin{block}{NCOA2}
            \begin{enumerate}
                \item Down-regulated in CIS of MSP-higher compared to MSP-lower.
                \item Nuclear Receptor Co-activator 2
                \item Critical regulator of glucose metabolism \cite{NCOA2-1}.
                \item NCOA2 expression correlates with leukocytes in head and neck cancer \cite{NCOA2-2}: \\
                    B-cells, T-cells, Neutrophils, Macrophages \& Dendritic cells
                \item NCOA2 promotes cancer cell growth in breast cancer \cite{NCOA2-3} ??
                \item NCOA2 knockdown inhibits growth \& progression of gastric cancer \cite{NCOA2-4} ??
            \end{enumerate}
        \end{block}

        \begin{block}{LAMTOR4}
            \begin{enumerate}
                \item Up-regulated in Normal of MSP-higher compared to MSP-lower.
                \item Late endosomal Adaptor, MTOR activator 4
                \item Ragulator complex that involved in mTORC1 \cite{LAMTOR4-1} \\
                $\therefore$ Promoting cell growth \& energy level
                \item LAMTOR4 may have therapeutic implications in cancer treatment by mammalian cell lines \cite{LAMTOR4-2}.
            \end{enumerate}
        \end{block}

        \begin{block}{HLA-DRB1}
            \begin{enumerate}
                \item Down-regulated in MSP-higher compared to MSP-lower.
                \item Involved in many depleted pathways in Normal.
                \item MHC complex, Class II, DR beta 1
                \item Present antigenic peptides that involves in phagocytosis of apoptotic tumor cells \cite{HLA-DRB1-1}.
                \item HLA-DRB1 is correlated with survival and prognosis in melanoma \cite{HLA-DRB1-2}.
                \item Negatively correlated with prognosis in LUAD \cite{TNFRSF14-2}.
            \end{enumerate}
        \end{block}

        \begin{block}{COX7B}
            \begin{enumerate}
                \item Down-regulated in CIS of MSP-higher compared to MSP-lower.
                \item Cytochrome C Oxidase sub-unit 7B
                \item The last enzyme in mitochondrial electron transport chain \cite{COX7B-1}.
                \item Inhibition of COX7B reduces sensitivity of cisplatin \\
                    $\Rightarrow$ Chemosensitivity in cancers \cite{COX7B-3}.
                \item COX7B  is correlated with sensitivity of various drugs \cite{COX7B-2}.
            \end{enumerate}
        \end{block}
    \end{frame}

    \begin{frame}
        \frametitle{Findings in DEG Analysis}
    \end{frame}

        \subsection{Bulk Cell Deconvolution}
    \begin{frame}
        \frametitle{BisqueRNA?}

        \begin{figure}
            \includegraphics[width=0.6 \linewidth]{figures/Workflow/Bisque.jpg}
            \caption{Workflow for BisqueRNA \protect\cite{Bisque1}}
        \end{figure}
    \end{frame}

    \subsubsection{Reference by \protect\citeA{singlecell1}}
    \begin{frame}
         \frametitle{Reference Single-cell Data (GSE131907)}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/LungCancer/reference_1.jpg}
            \caption{Comprehensive dissection and clustering of 208,506 single cells from LUAD patients \protect\cite{singlecell1}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Cluster Plot in LUSC}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/BisqueRNA/clustermap/STAR.FPKM.GSE131907.SQC.pdf}
            \caption{Cluster Plot in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Violin Plots upon Cancer Stages in LUSC}

        \begin{figure}
            $\begin{array}{c}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE131907.SQC/ExhaustedTfh.pdf} \\
                \mbox{(a) Exhausted Tfh} \\
            \end{array}$
            \caption{Down-regulated cell types in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE131907.SQC/AT1.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE131907.SQC/AT2.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE131907.SQC/FollicularBcells.pdf}
                \\
                \mbox{(a) AT1} & \mbox{(b) AT2} & \mbox{(c) Follicular B cells} \\
            \end{array}$
            \caption{Up-regulated cell types in CIS \& Primary of LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE131907.SQC/mo-Mac.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE131907.SQC/tS1.pdf}
                \\
                \mbox{(d) mo-Mac} & \mbox{(e) tS1} \\
            \end{array}$
            \caption{Up-regulated cell types in CIS \& Primary of LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE131907.SQC/CD1c+DCs.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE131907.SQC/CD4+Th.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE131907.SQC/CD8lowT.pdf}
                \\
                \mbox{(a) CD1c+ DCs} & \mbox{(b) CD4+ Th} & \mbox{(c) CD8-low T} \\
            \end{array}$
            \caption{Down-regulated cell types in CIS \& Primary of LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE131907.SQC/Ciliated.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE131907.SQC/MALTBcells.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE131907.SQC/PleuralMac.pdf}
                \\
                \mbox{(d) Ciliated} & \mbox{(e) MALT B cells} & \mbox{(f) Pleural Mac} \\
            \end{array}$
            \caption{Down-regulated cell types in CIS \& Primary of LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{c}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE131907.SQC/Treg.pdf} \\
                \mbox{(g) Treg} \\
            \end{array}$
            \caption{Down-regulated cell types in CIS \& Primary of LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in GSE131907 upon Stages in LUSC}

        \begin{block}{Exhausted T follicular helper (Tfh)}
            \begin{enumerate}
                \item Down-regulated in CIS compared to Normal.
                \item Down-regulated in Primary compare to Primary.
                \item Tfh response controls chronic viral infection \cite{Tfh-1}.
                \item HBV dysregulates B cells-Tfh cell axis \cite{Tfh-2}.
                \item Tfh cells have a major role in humoral immunity \\
                    by regulating cellular reactions \cite{Tfh-3}.
                \item Tfh restore antitumor immunity \& anti-PD-L1 efficacy \cite{Tfh-4}.
            \end{enumerate}
        \end{block}

        \begin{block}{Alveolar types I \& II (AT1 \& AT2)}
            \begin{enumerate}
                \item Up-regulated in CIS \& Primary compared to Normal.
                \item AT1 \& AT2 are the most abundant cell types \cite{singlecell1}.
                \item AT1 \& AT2 initiated LUAD in distal way \cite{AT1-1}.
            \end{enumerate}
        \end{block}

        \begin{block}{Follicular B cells}
            \begin{enumerate}
                \item Up-regulated in CIS \& Primary compared to Normal.
                \item Follicular B cells are correlated with a better long-term survival in lung cancer \cite{Bf-1} ?
                \item Lung cancer patients with high tumor-associated antigen reactive Ig \\
                    tend to have high follicular B cells \cite{Bf-1}.
                \item Low density of follicular B cells $\Rightarrow$ High risk of poor survival of NSCLC \cite{Bcell-2} ?
            \end{enumerate}
        \end{block}

        \begin{block}{Monocytes \& Macrophages (mo-Mac)}
            \begin{enumerate}
                \item Up-regulated in CIS \& Primary compared to Normal.
                \item Plasticity of mo-Mac can be re-educated and exert anti-cancer function \cite{moMac-2}.
                \item Tumor-associated mo-Mac dampen anti-tumor immune response in lung cancer \cite{moMac-1}.
                \item Interaction of mo-Mac with ovarian cancer cells promote angiogenesis \cite{moMac-3}.
                \item Tumor-infiltrating mo-Mac promote tumor invasion \& migration \cite{moMac-4}.
            \end{enumerate}
        \end{block}

        \begin{block}{Transcriptional state I (tS1)}
            \begin{enumerate}
                \item Up-regulated in CIS \& Primary compared to Normal.
                \item tS1 is along with normal epithelial cells in LUAD \cite{singlecell1}. \\
                    $\therefore$ tS1 represented a de-regulation of the normal differentiation programs.
                \item tS1-high patients have worse survival in TCGA-LUSC (p=0.07) \cite{singlecell1}.
            \end{enumerate}
        \end{block}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Cluster Plots upon MSP in LUSC}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/BisqueRNA/clustermap/STAR.FPKM.GSE131907.SQC.MSP-median/Mutation Shared Proportion-All.pdf}
            \caption{Cluster Plot upon MSP in LUSC}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/BisqueRNA/clustermap/STAR.FPKM.GSE131907.SQC.MSP-median/Mutation Shared Proportion-Normal.pdf}
            \caption{Cluster Plot upon MSP in Normal of LUSC}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/BisqueRNA/clustermap/STAR.FPKM.GSE131907.SQC.MSP-median/Mutation Shared Proportion-CIS+AIS.pdf}
            \caption{Cluster Plot upon MSP in CIS of LUSC}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/BisqueRNA/clustermap/STAR.FPKM.GSE131907.SQC.MSP-median/Mutation Shared Proportion-Primary.pdf}
            \caption{Cluster Plot upon MSP in Primary of LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Violin Plots upon MSP in LUSC}
        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.GSE131907.SQC.MSP-median/Mutation Shared Proportion-AT1.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.GSE131907.SQC.MSP-median/Mutation Shared Proportion-COL13A1+matrixFBs.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.GSE131907.SQC.MSP-median/Mutation Shared Proportion-mo-Mac.pdf}
                \\
                \mbox{(a) AT1} & \mbox{(b) COL13A1+ FBs} & \mbox{(c) mo-Mac} \\
            \end{array}$
            \caption{Up-regulated cell types in MSP-Higher of LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.GSE131907.SQC.MSP-median/Mutation Shared Proportion-CD4+Th.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.GSE131907.SQC.MSP-median/Mutation Shared Proportion-Ciliated.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.GSE131907.SQC.MSP-median/Mutation Shared Proportion-Treg.pdf}
                \\
                \mbox{(a) CD4+ Th} & \mbox{(b) Ciliated} & \mbox{(c) Treg} \\
            \end{array}$
            \caption{Down-regulated cell types in MSP-Higher of LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.GSE131907.SQC.MSP-median/Mutation Shared Proportion-MALTBcells.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.GSE131907.SQC.MSP-median/Mutation Shared Proportion-PleuralMac.pdf}
                \\
                \mbox{(d) MALT B cells} & \mbox{(e) Pleural Mac} \\
            \end{array}$
            \caption{Down-regulated cell types in MSP-Higher of LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in GSE131907 upon MSP in LUSC}

        \begin{block}{Alveolar type I (AT1)}
            \begin{enumerate}
                \item Up-regulated only in CIS \& Primary of MSP-higher.
                \item AT1 are the most abundant cell types \cite{singlecell1}.
                \item AT1 cover almost gas exchange surface, and are thin to facilitate gas diffusion \cite{AT1-2}.
                \item AT1 initiated LUAD in distal way \cite{AT1-1}.
            \end{enumerate}
        \end{block}

        \begin{block}{COL13A1+ fibroblasts (FBs)}
            \begin{enumerate}
                \item Up-regulated only in CIS \& Primary of MSP-higher.
                \item COL13A1+ FBs are the main FB types in normal lung \& early stage tumor \cite{singlecell1}.
                \item FBs undergo temporal activation changes throughout healing response \\
                    $\therefore$ FBs: the arbiters of ECM remodeling \cite{FB-1}.
                \item Over-expression of COL13A1 is associated \\
                    with high risk of disease progression \& aggressive invasion in urothelial carcinoma \cite{COL13A1-1}.
            \end{enumerate}
        \end{block}

        \begin{block}{Monocytes \& Macrophages (mo-Mac)}
            \begin{enumerate}
                \item Up-regulated only in CIS \& Primary of MSP-higher.
                \item Plasticity of mo-Mac can be re-educated and exert anti-cancer function \cite{moMac-2}.
                \item Tumor-associated mo-Mac dampen anti-tumor immune response in lung cancer \cite{moMac-1}.
                \item Interaction of mo-Mac with ovarian cancer cells promote angiogenesis \cite{moMac-3}.
                \item Tumor-infiltrating mo-Mac promote tumor invasion \& migration \cite{moMac-4}.
            \end{enumerate}
        \end{block}

        \begin{block}{CD4+ T helper (Th)}
            \begin{enumerate}
                \item Down-regulated only in CIS \& Primary of MSP-higher.
                \item CD4+ Th play a central role in immune protection \cite{CD4+Tcell-1}.
                    \begin{itemize}
                        \item to help B cells make antibodies
                        \item to induce macrophages to develop microbicidal activity
                        \item to recruit neutrophils, eosinophils, \& basophils
                    \end{itemize}
                \item Resting CD4+ T cells negatively correlates with survival in NSCLC \cite{CD4+Tcell-2}.
            \end{enumerate}
        \end{block}

        \begin{block}{Ciliated}
            \begin{enumerate}
                \item Down-regulated only in CIS \& Primary of MSP-higher.
                \item Ciliated cells are differentiated cell population \cite{ciliated-1}.
                \item Environmental pollutant, including smoking, damage epithelial cell cilia \cite{ciliated-2}.
                \item Ciliated cells are suspected to be able to give rise to LUAD in specific conditions \cite{ciliated-3}.
            \end{enumerate}
        \end{block}

        \begin{block}{T regulatory (Treg)}
            \begin{enumerate}
                \item Down-regulated only in CIS \& Primary of MSP-higher.
            \end{enumerate}
        \end{block}

        \begin{block}{MALT B cells}
            \begin{enumerate}
                \item Down-regulated only in CIS \& Primary of MSP-higher.
            \end{enumerate}
        \end{block}

        \begin{block}{Pleural Macrophages (Mac)}
            \begin{enumerate}
                \item Down-regulated only in CIS \& Primary of MSP-higher.
            \end{enumerate}
        \end{block}
    \end{frame}

    \begin{frame}
        \frametitle{Cluster Plot in LUAD}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/BisqueRNA/clustermap/STAR.FPKM.GSE131907.ADC.pdf}
            \caption{Cluster Plot in LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Violin Plots in LUAD}

        \begin{figure}
            \caption{Up-regulated cell types in LUAD}
        \end{figure}

        \begin{figure}
            \caption{Down-regulated cell types in LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in GSE131907 with LUAD}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in GSE131907}
    \end{frame}

    \subsubsection{Reference by \protect\citeA{singlecell2}}
    \begin{frame}
        \frametitle{Reference Single-cell Data (GSE162498)}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/LungCancer/reference_2.png}
            \caption{Characterization of CD3$^+$ TILs in NSCLC \protect\cite{singlecell2}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Cluster Plots in LUSC}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/BisqueRNA/clustermap/STAR.FPKM.GSE162498.SQC.pdf}
            \caption{Cluster Plot in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Violin Plots in LUSC}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.SQC/CD4-CCR8.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.SQC/CD4-GZMA.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.SQC/CD4-SELL.pdf}
                \\
                \mbox{(a) CD4-CCR8} & \mbox{(b) CD4-GZMA} & \mbox{(c) CD4-SELL} \\
            \end{array}$
            \caption{Up-regulated cell types in LUSC}
        \end{figure}

         \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.SQC/CD8-LAYN.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.SQC/CD48-MCM5.pdf}
                \\
                \mbox{(d) CD8-LAYN} & \mbox{(e) CD48-MCM5} \\
            \end{array}$
            \caption{Up-regulated cell types in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.SQC/CD4-IL32.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.SQC/CD4-MAL.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.SQC/CD8-GZMH.pdf}
                \\
                \mbox{(a) CD4-IL32} & \mbox{(b) CD4-MAL} & \mbox{(c) CD8-GZMH} \\
            \end{array}$
            \caption{Down-regulated cell types in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.SQC/CD8-SLC4A10.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.SQC/CD48-TOP2A.pdf}
                \\
                \mbox{(d) CD8-SLC4A10} & \mbox{(e) CD48-TOP2A} \\
            \end{array}$
            \caption{Down-regulated cell types in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in GSE162498 upon Cancer stages with LUSC}

        \begin{block}{CD4-CCR8}
            \begin{enumerate}
                \item Up-regulated in CIS \& Primary.
                \item C-C motif Chemokine Receptor 8
                \item Regulate monocyte chemotaxis \& thymic cell line apoptosis \cite{CCR8-1}.
                \item Enhance migration, invasion, and epithelial-mesenchymal transition \cite{CCR8-2}.
                \item Targeting CCR8 induces anti-tumor immunity in colon cancer \cite{CCR8-3}.
                \item CCR8 is highly expressed in regulatory T-cell \\
                    $\therefore$ High CCR8 correlates with poor prognosis in breast cancer \cite{CCR8-4}.
            \end{enumerate}
        \end{block}

        \begin{block}{CD4-GZMA}
            \begin{enumerate}
                \item Up-regulated in CIS \& Primary.
                \item Granzyme A
                \item Activates caspase-independent pyroptosis in leukocytes \\
                    including T-cell \& NK-cell \cite{GZMA-1, GZMA-2, GZMA-3}.
                \item Extracellular GZMA promotes colorectal cancer development \cite{GZMA-4}.
            \end{enumerate}
        \end{block}

        \begin{block}{CD4-SELL}
            \begin{enumerate}
                \item Up-regulated in CIS \& Primary.
                \item Selectin L
                \item Promotes initial tethering and rolling of leukocytes in endothelia \cite{SELL-1, SELL-2}
                \item Higher expression of SELL is associated with better survival overcome \cite{SELL-3} ?
            \end{enumerate}
        \end{block}

        \begin{block}{CD8-LAYN}
            \begin{enumerate}
                \item Up-regulated in CIS \& Primary.
                \item Layillin
                \item Receptor for hyaluronate \cite{LAYN-1}.
                \item High LAYN expression is correlated with poor OS \& PFS in gastric cancer \cite{LAYN-2}.
                \item LAYN is a known exhausted marker in NSCLC \cite{LAYN-3}.
            \end{enumerate}
        \end{block}

        \begin{block}{CD48-MCM5}
            \begin{enumerate}
                \item Up-regulated in CIS \& Primary.
                \item Mini-chromosome Maintenance complex component 5
                \item Replicative helicase that essential for DNA replication \& elongation \cite{MCM5-1, MCM5-2}.
                \item MCM5 \& MCM7 indicate possible role in proliferation of NSCLC \cite{MCM5-3}.
                \item High expression of MCM5 have shorter OS in LUSC \cite{MCM5-4}.
            \end{enumerate}
        \end{block}

        \begin{block}{CD4-IL32}
            \begin{enumerate}
                \item Down-regulated in CIS \& Primary.
                \item Interleukin-32
                \item Cytokine involved in innate \& adaptive immune response \cite{IL32-1}.
                \item IL32 promote tumor invasion and metastasis in breast cancer \cite{IL32-2}.
                \item Positive IL32 expression had shorter OS in colon cancer \cite{IL32-3}.
                \item Increased IL32 expression in LUAD \cite{IL32-4} \\
                    $\Rightarrow$ correspond to clinical stage, lymph node metastases, \& distance metastasis
            \end{enumerate}
        \end{block}

        \begin{block}{CD4-MAL}
            \begin{enumerate}
                \item Down-regulated in CIS \& Primary.
                \item Myelin and Lymphocyte protein
                \item Vesicular trafficking cycling between Golgi complex \& apical plasma membrane \cite{MAL-1}.
                \item DNA hyper-methlyation of MAL in cervical cancer \& precursor lesions \cite{MAL-2}.
            \end{enumerate}
        \end{block}

        \begin{block}{CD8-GZMH}
            \begin{enumerate}
                \item Down-regulated in CIS \& Primary.
                \item Granzyme H
                \item Necessary for target cell lysis in cell-mediated immune responses \cite{GZMH-1, GZMH-2}.
                \item Exhaustion signature in NSCLC \cite{GZMH-3} ?
                \item \textit{A. muciniphila}-negative NSCLC patient had lower expression of GZMH \& worse OS \cite{GZMH-4}.
            \end{enumerate}
        \end{block}

        \begin{block}{CD8-SLC4A10}
            \begin{enumerate}
                \item Down-regulated in CIS \& Primary.
                \item Solute Carrier Family 4 member 10
                \item Sodium/bicarbonate co-transporter that regulates intracellular pH \cite{SLC4A10-1}.
                \item Genetic distruption of SLC4A10 reduces several mitochondrial enzymes \cite{SLC4A10-2}.
                \item Patients who had lower SLC4A10 expression in CD8+ T-cell \\
                    had lower disease free survival in liver cancer \cite{SLC4A10-3}.
            \end{enumerate}
        \end{block}

        \begin{block}{CD48-TOP2A}
            \begin{enumerate}
                \item Down-regulated in CIS \& Primary.
                \item DNA Topoisomerase II Alpha
                \item Alters DNA topology \cite{TOP2A-1}.
                \item Over-expression of TOP2A in bladder urothelial carcinoma \cite{TOP2A-2} ?
                \item TOP2A promotes tumor progression and predicts poor prognosis in LUAD \cite{TOP2A-3} ?
                \item TOP2A: Prognostic marker in NSCLC \cite{TOP2A-4}.
            \end{enumerate}
        \end{block}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Cluster Plots upon MSP in LUSC}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/BisqueRNA/clustermap/STAR.FPKM.GSE162498.SQC.MSP-median/Mutation Shared Proportion-All.pdf}
            \caption{Cluster Plot upon MSP in LUSC}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/BisqueRNA/clustermap/STAR.FPKM.GSE162498.SQC.MSP-median/Mutation Shared Proportion-Normal.pdf}
            \caption{Cluster Plot upon MSP in Normal of LUSC}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/BisqueRNA/clustermap/STAR.FPKM.GSE162498.SQC.MSP-median/Mutation Shared Proportion-CIS+AIS.pdf}
            \caption{Cluster Plot upon MSP in CIS of LUSC}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/BisqueRNA/clustermap/STAR.FPKM.GSE162498.SQC.MSP-median/Mutation Shared Proportion-Primary.pdf}
            \caption{Cluster Plot upon MSP in Primary of LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Violin Plots upon MSP in LUSC}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.SQC.MSP-median/Mutation Shared Proportion-CD8-LAYN.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.SQC.MSP-median/Mutation Shared Proportion-CD48-MCM5.pdf}
                \\
                \mbox{(a) CD8-LAYN} & \mbox{(b) CD48-MCM5} \\
            \end{array}$
            \caption{Up-regulated cell types in CIS \& Primary of MSP-higher}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.SQC.MSP-median/Mutation Shared Proportion-CD8-GZMH.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.SQC.MSP-median/Mutation Shared Proportion-CD8-SLC4A10.pdf}
                \\
                \mbox{(a) CD8-GZMH} & \mbox{(b) CD8-SLC4A10} \\
            \end{array}$
            \caption{Down-regulated cell types in CIS \& Primary of MSP-higher}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in GSE162498 upon MSP in LUSC}

        \begin{block}{CD8-LAYN}
            \begin{enumerate}
                \item Up-regulated in CIS of MSP-higher than MSP-lower.
                \item Layillin
                \item Receptor for hyaluronate \cite{LAYN-1}.
                \item High LAYN expression is correlated with poor OS \& PFS \\
                    in gastric cancer \cite{LAYN-2}.
                \item LAYN is a known exhausted marker in NSCLC \cite{LAYN-3}.
            \end{enumerate}
        \end{block}

        \begin{block}{CD8-MCM5}
            \begin{enumerate}
                \item Up-regulated in CIS of MSP-higher than MSP-lower.
                \item Mini-chromosome Maintenance complex component 5
                \item Replicative helicase that essential for DNA replication \& elongation \cite{MCM5-2}.
                \item MCM5 \& MCM7 indicate possible role in proliferation of NSCLC \cite{MCM5-3}.
                \item High expression of MCM5 have shorter OS in LUSC \cite{MCM5-4}.
            \end{enumerate}
        \end{block}

        \begin{block}{CD8-GZMH}
            \begin{enumerate}
                \item Down-regulated only in CIS \& Primary of MSP-higher.
                \item Granzyme H
                \item Necessary for target cell lysis in cell-mediated immune responses \cite{GZMH-1, GZMH-2}.
                \item Exhaustion signature in NSCLC \cite{GZMH-3} ??
                \item \textit{A. muciniphila}-negative NSCLC patient had lower expression of GZMH \& worse OS \cite{GZMH-4}.
            \end{enumerate}
        \end{block}

        \begin{block}{CD8-SLC4A10}
            \begin{enumerate}
                \item Down-regulated only in CIS \& Primary of MSP-higher.
                \item Solute Carrier Family 4 member 10
                \item Sodium/bi-carbonate co-transporter that regulates intracellular pH \cite{SLC4A10-1}.
                \item Genetic disruption of SLC4A10 reduces several mitochondrial enzymes \cite{SLC4A10-2}.
            \end{enumerate}
        \end{block}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in GSE162498 with LUSC}
    \end{frame}

    \begin{frame}
        \frametitle{Cluster Plot in LUAD}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/BisqueRNA/clustermap/STAR.FPKM.GSE162498.ADC.pdf}
            \caption{Cluster Plot in LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Violin Plots in LUAD}

        \begin{figure}
            $\begin{array}{c}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.ADC/CD4-SESN1.pdf} \\
                \mbox{(a) CD4-SESN1} \\
            \end{array}$
            \caption{Up-regulated cell types in LUAD}
        \end{figure}

        \begin{figure}
            $\begin{array}{c}
                \includegraphics[width=0.3 \linewidth]{figures/BisqueRNA/violin/STAR.FPKM.GSE162498.ADC/CD4-TNFRSF18.pdf} \\
                \mbox{(a) CD4-TNFRSF18} \\
            \end{array}$
            \caption{Up-regulated cell types in LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in GSE162498 with LUAD}

        \begin{block}{CD4-SESN1}
            \begin{enumerate}
                \item CD4-SESN1 is up-regulated in CIS \& Primary.
                \item Sestrin 1
                \item Stress-inducible metabolic regulator that play a role in protection against oxidative \& genotoxic stresses \cite{SESN1-1, SESN1-2, SESN1-3}.
                \item Oncogenic mutant p53 isoforms inhibit SESN1 expression in chronic lymphocytic leukemia \cite{SESN1-4}.
                \item Inactivation of SESN1 accelerates cell proliferation \& resistance to cell death in LUAD \cite{SESN1-5}.
            \end{enumerate}
        \end{block}

         \begin{block}{CD4-TNFRSF18}
            \begin{enumerate}
                \item CD4-TNFRSF18 is down-regulated in CIS \& Primary.
                \item Tumor Necrosis Factor Receptor Superfamily Member 18
                \item Involved in T-cell \& endothelial cells in TCR-mediated cell death \cite{TNFRSF18-1}.
                \item TNFRSF18 is negatively correlated with survival in endometrial cancer \cite{TNFRSF18-2}.
            \end{enumerate}
        \end{block}
    \end{frame}

    \subsubsection{TIMER}
    \begin{frame}
        \frametitle{TIMER?}

        \begin{figure}
            \includegraphics[width=0.5 \linewidth]{figures/Workflow/TIMER.jpg}
            \caption{Overview of TIMER modules \protect\cite{TIMER-1}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Cluster Plots in LUSC}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/TIMER/Clustermap/STAR.FPKM.SQC/TIMER-All.pdf}
            \caption{Cluster Plot in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Violin Plots in LUSC}

        \begin{figure}
            $\begin{array}{c}
                \includegraphics[width=0.3 \linewidth]{figures/TIMER/Violin/STAR.FPKM.SQC/TIMER-Myeloid dendritic cell.pdf} \\
                \mbox{(a) Myeloid dendritic cell} \\
            \end{array}$
            \caption{Up-regulated cell types in LUSC}
        \end{figure}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.3 \linewidth]{figures/TIMER/Violin/STAR.FPKM.SQC/TIMER-Macrophage.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/TIMER/Violin/STAR.FPKM.SQC/TIMER-T cell CD8+.pdf}
                \\
                \mbox{(a) Macrophage} & \mbox{(b) T cell CD8+} \\
            \end{array}$
            \caption{Down-regulated cell types in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Cluster Plots upon MSP in LUSC}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/TIMER/Clustermap/STAR.FPKM.SQC.MSP-median/Mutation Shared Proportion-TIMER-All.pdf}
            \caption{Cluster Plot upon MSP in LUSC}
        \end{figure}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/TIMER/Clustermap/STAR.FPKM.SQC.MSP-median/Mutation Shared Proportion-TIMER-Normal.pdf}
            \caption{Cluster Plot upon MSP in Normal of LUSC}
        \end{figure}

         \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/TIMER/Clustermap/STAR.FPKM.SQC.MSP-median/Mutation Shared Proportion-TIMER-CIS+AIS.pdf}
            \caption{Cluster Plot upon MSP in CIS of LUSC}
        \end{figure}

         \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/TIMER/Clustermap/STAR.FPKM.SQC.MSP-median/Mutation Shared Proportion-TIMER-Primary.pdf}
            \caption{Cluster Plot upon MSP in Primary of LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Violin Plots upon MSP in LUSC}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/TIMER/Violin/STAR.FPKM.SQC.MSP-median/Mutation Shared Proportion-TIMER-B cell.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/TIMER/Violin/STAR.FPKM.SQC.MSP-median/Mutation Shared Proportion-TIMER-Neutrophil.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/TIMER/Violin/STAR.FPKM.SQC.MSP-median/Mutation Shared Proportion-TIMER-T cell CD4+.pdf}
                \\
                \mbox{(a) B cell} & \mbox{(b) Neutrophil} & \mbox{(a) T cell CD4+} \\
            \end{array}$
            \caption{Down-regulated cell types upon MSP in LUSC}
        \end{figure}

         \begin{figure}
             $\begin{array}{c}
                 \includegraphics[width=0.3 \linewidth]{figures/TIMER/Violin/STAR.FPKM.SQC.MSP-median/Mutation Shared Proportion-TIMER-T cell CD8+.pdf}
                 \\
                 \mbox{(d) T cell CD8+} \\
             \end{array}$
            \caption{Down-regulated cell types upon MSP in LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in TIMER with LUSC}

        \begin{block}{B-cell}
            \begin{enumerate}
                \item Down-regulated in CIS of MSP-higher than MSP-lower.
                \item Roles of B-cells in tumor micro-environment \cite{Bcell-1}.
                \item Tumor-infiltrating B-cell have pro- \& anti-tumor effects \cite{Bcell-2}.
            \end{enumerate}
        \end{block}

         \begin{block}{Neutrophil}
            \begin{enumerate}
                \item Down-regulated in CIS of MSP-higher than MSP-lower.
                \item Down-regulated in Primary than CIS in MSP-lower.
            \end{enumerate}
        \end{block}

         \begin{block}{CD4+ T-cell}
            \begin{enumerate}
                \item Down-regulated in Normal of MSP-higher than MSP-lower.
                \item Down-regulated in CIS of MSP-higher than MSP-lower.
                \item Down-regulated in Primary of MSP-higher than MSP-lower.
            \end{enumerate}
        \end{block}

         \begin{block}{CD8+ T-cell}
            \begin{enumerate}
                \item Down-regulated in CIS than Normal in MSP-higher.
            \end{enumerate}
        \end{block}
    \end{frame}

    \begin{frame}
        \frametitle{Cluster Plots in LUAD}

        \begin{figure}
            \includegraphics[width=0.9 \linewidth]{figures/TIMER/Clustermap/STAR.FPKM.ADC/TIMER-All.pdf}
            \caption{Cluster Plot in LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Violin Plots in LUAD}

        \begin{figure}
            $\begin{array}{c}
                \includegraphics[width=0.3 \linewidth]{figures/TIMER/Violin/STAR.FPKM.ADC/TIMER-T cell CD8+.pdf}\\
                \mbox{(a) T cell CD8+} \\
            \end{array}$
            \caption{Down-regulated cell types in LUAD}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Findings in TIMER with LUAD}

        \begin{block}{CD8+ T-cell}
            \begin{enumerate}
                \item CD8+ T-cell is down-regulated in Primary.
                \item Antigen recognition of CD8+ T-cell in tumor micro-environment \cite{CD8+Tcell-1}.
                \item CD8+ T-cells have roles in anti-cancer immunity \& immunotherapy \cite{CD8+Tcell-2}.
                \item Presence of CD8+ T-cells is negatively correlated with survival in breast cancer \cite{CD8+Tcell-3}.
            \end{enumerate}
        \end{block}
    \end{frame}

    \begin{frame}
        \frametitle{Findings in Bulk Cell Deconvolution}
    \end{frame}

    \subsection{Identification of Microbial Sequences}
    \begin{frame}
        \frametitle{PathSeq?}

        \begin{figure}
            \includegraphics[width=0.8 \linewidth]{figures/Workflow/PathSeq.png}
            \caption{PathSeq Pipeline Diagram \protect\cite{pathseq1, pathseq2}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Taxonomy Class}

        \begin{block}{Taxonomy Class}
            \begin{enumerate}
                \item Kingdom
                \item Phylum
                \item Class
                \item Order
                \item Family
                \item Genus
                \item Species
            \end{enumerate}
        \end{block}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{LUSC Taxonomy Distribution}

        \begin{table}
            \caption{Number of WTS samples}
            \input{tables/WTS_samples/WTS_samples.tex}
        \end{table}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.35 \linewidth]{figures/PathSeq/WTS/STAR/Bar/Bar-STAR-SQC.genus.pdf}
                &
                \includegraphics[width=0.35 \linewidth]{figures/PathSeq/WTS/STAR/Bar/Bar-STAR-SQC.species.pdf}
                \\
                \mbox{(a) Genus level} & \mbox{(b) Species level} \\
            \end{array}$
            \caption{Taxonomy Distribution of LUSC}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Differentially expressed taxa -- Genus level}

        \begin{block}{Differentially expressed genera}
            58 / 1770 (3.28 \%) genera passed K.W. test (p $<$ 0.01)
        \end{block}

        \begin{figure}
            \includegraphics[width=0.4 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.genus/Thermomonospora.pdf}
            \caption{Differentially expressed genus}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.genus/Achromobacter.pdf}
                &
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.genus/Ferrovum.pdf}
                &
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.genus/Reyranella.pdf}
                \\

                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.genus/Ancylobacter.pdf}
                &
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.genus/Candidatus_Schmidhempelia.pdf}
                &
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.genus/Labrys.pdf}
                \\
            \end{array}$
            \caption{Differentially expressed genera -- Normal vs. CIS}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.genus/Anabaena.pdf}
                &
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.genus/Calothrix.pdf}
                &
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.genus/Formosa.pdf}
                \\
            \end{array}$
            \caption{Differentially expressed genera -- CIS vs. Primary}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Differentially expressed taxa -- Species level}

        \begin{block}{Differentially expressed species}
            286 / 11880 (2.41 \%) species passed K.W. test (p $<$ 0.01)
        \end{block}

        \begin{figure}
            \includegraphics[width=0.4 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.species/Thermomonospora_curvata.pdf}
            \caption{Differentially expressed species}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.species/Achromobacter_sp._HMSC057D05.pdf}
                &
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.species/Ferrovum_sp._PN-J185.pdf}
                &
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.species/Reyranella_massiliensis.pdf}
                \\

                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.species/Ancylobacter_sp._FA202.pdf}
                &
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.species/Candidatus_Schmidhempelia_bombi.pdf}
                &
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.species/Labrys_sp._WJW.pdf}
                \\
            \end{array}$
            \caption{Differentially expressed species -- Normal vs. CIS}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.species/Anabaena_cylindrica.pdf}
                &
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.species/Calothrix_sp._PCC_7507.pdf}
                &
                \includegraphics[width=0.25 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.species/Formosa_haliotis.pdf}
                \\
            \end{array}$
            \caption{Differentially expressed species -- CIS vs. Primary}
        \end{figure}
    \end{frame}

    \subsubsection{LUSC Taxonomy Distribution upon MSP}
    \begin{frame}[allowframebreaks]
        \frametitle{LUSC Taxonomy Distribution -- MSP}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.4 \linewidth]{figures/PathSeq/WTS/STAR/Bar/Bar-STAR-SQC.MutationSharedProportion-Median.genus.pdf}
                &
                \includegraphics[width=0.4 \linewidth]{figures/PathSeq/WTS/STAR/Bar/Bar-STAR-SQC.MutationSharedProportion-Median.species.pdf}
                \\
                \mbox{(a) Genus level} & \mbox{(b) Species level} \\
            \end{array}$
            \caption{Taxonomy Distribution of LUSC by MSP}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Differentially expressed taxa -- MSP -- Genus level}

        \begin{block}{Differentially expressed genera}
            59 / 1770 (3.33 \%) genera passed K.W. test (p $<$ 0.01)
        \end{block}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.MutationSharedProportion-Median.genus/Geobacillus.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.MutationSharedProportion-Median.genus/Micrococcus.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.MutationSharedProportion-Median.genus/Rhodocista.pdf}
                \\
            \end{array}$
            \caption{Differentially expressed genera in MSP}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.MutationSharedProportion-Median.genus/Nitratireductor.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.MutationSharedProportion-Median.genus/Paenarthrobacter.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.MutationSharedProportion-Median.genus/Sinomonas.pdf}
                \\
            \end{array}$
            \caption{Differentially expressed genera in MSP -- CIS \& Primary}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{Differentially expressed taxa -- MSP -- Species level}

        \begin{block}{Differentially expressed genera}
            270 / 11880 (2.27 \%) species passed K.W. test (p $<$ 0.01)
        \end{block}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.MutationSharedProportion-Median.species/Geobacillus_sp._G11MC16.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.MutationSharedProportion-Median.species/Micrococcus_aloeverae.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.MutationSharedProportion-Median.species/Rhodocista_sp._MIMtkB3.pdf}
                \\
            \end{array}$
            \caption{Differentially expressed genera in MSP}
        \end{figure}

        \begin{figure}
            $\begin{array}{ccc}
                \includegraphics[width=0.3 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.MutationSharedProportion-Median.species/Nitratireductor_sp._ZZ-1.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.MutationSharedProportion-Median.species/Paenarthrobacter_aurescens.pdf}
                &
                \includegraphics[width=0.3 \linewidth]{figures/PathSeq/WTS/STAR/Violin/Violin-STAR-SQC.MutationSharedProportion-Median.species/Sinomonas_atrocyanea.pdf}
                \\
            \end{array}$
            \caption{Differentially expressed genera in MSP -- CIS \& Primary}
        \end{figure}
    \end{frame}

    \begin{frame}[allowframebreaks]
        \frametitle{LUAD Taxonomy Distribution}

        \begin{table}
            \caption{Number of WTS samples}
            \input{tables/WTS_samples/WTS_samples.tex}
        \end{table}

        \begin{figure}
            $\begin{array}{cc}
                \includegraphics[width=0.35 \linewidth]{figures/PathSeq/WTS/STAR/Bar/Bar-STAR-ADC.genus.pdf}
                &
                \includegraphics[width=0.35 \linewidth]{figures/PathSeq/WTS/STAR/Bar/Bar-STAR-ADC.species.pdf}
                \\
                \mbox{(a) Genus level} & \mbox{(b) Species level} \\
            \end{array}$
            \caption{Taxonomy Distribution of LUAD}
        \end{figure}
    \end{frame}

%    \begin{frame}
%        \frametitle{Diversity Indices}
%
%        \begin{figure}
%            \includegraphics[width=0.6 \linewidth]{figures/PathSeq/phylogenic.jpg}
%            \caption{Three dimensions of phylogenic information \protect\cite{phylogenetic1}}
%        \end{figure}
%
%        \begin{itemize}
%            \item A quantitative measure that shows richness, divergence, and regularity \cite{phylogenetic1}
%            \item Alpha diversity indices: the richness of taxa \textbf{at a single community}
%            \item Beta diversity indices: the taxonomic differentiation \textbf{between communities}
%        \end{itemize}
%    \end{frame}

    \begin{frame}
        \frametitle{Findings in Identification of Microbial Sequences}
    \end{frame}

    \subsection{Discovery of Gene Fusion}
    \begin{frame}
        \frametitle{Arriba?}

        \begin{figure}
            \includegraphics[width=0.6 \linewidth]{figures/Workflow/Arriba.png}
            \caption{Benchmark of Arriba versus alternative methods \protect\cite{Arriba1}}
        \end{figure}
    \end{frame}

    \begin{frame}
        \frametitle{Findings in Gene Fusion Discovery}
    \end{frame}

    \section{Discussion}

    \section{References}
    \begin{frame}[allowframebreaks]
        \frametitle{References}
        \bibliographystyle{apacite}
        \bibliography{reference}
    \end{frame}
\end{document}